<?properties open_access?>
<?DTDIdentifier.IdentifierValue -//ACS//DTD ACS Journal DTD v1.02 20061031//EN?>
<?DTDIdentifier.IdentifierType public?>
<?SourceDTD.DTDName ACSJournal-v102.dtd?>
<?SourceDTD.Version 1.02?>
<?ConverterInfo.XSLTName acs2nlmx2.xsl?>
<?ConverterInfo.Version 1?>
<front>
  <journal-meta>
    <journal-id journal-id-type="nlm-ta">J Chem Inf Model</journal-id>
    <journal-id journal-id-type="iso-abbrev">J Chem Inf Model</journal-id>
    <journal-id journal-id-type="publisher-id">ci</journal-id>
    <journal-id journal-id-type="coden">jcisd8</journal-id>
    <journal-title-group>
      <journal-title>Journal of Chemical Information and Modeling</journal-title>
    </journal-title-group>
    <issn pub-type="ppub">1549-9596</issn>
    <issn pub-type="epub">1549-960X</issn>
    <publisher>
      <publisher-name>American Chemical
Society</publisher-name>
    </publisher>
  </journal-meta>
  <article-meta>
    <article-id pub-id-type="pmcid">7189367</article-id>
    <article-id pub-id-type="doi">10.1021/acs.jcim.9b01120</article-id>
    <article-categories>
      <subj-group>
        <subject>Article</subject>
      </subj-group>
    </article-categories>
    <title-group>
      <article-title>Deep Generative Models for 3D Linker Design</article-title>
    </title-group>
    <contrib-group>
      <contrib contrib-type="author" id="ath1">
        <name>
          <surname>Imrie</surname>
          <given-names>Fergus</given-names>
        </name>
        <xref rid="aff1" ref-type="aff">†</xref>
      </contrib>
      <contrib contrib-type="author" id="ath2">
        <name>
          <surname>Bradley</surname>
          <given-names>Anthony R.</given-names>
        </name>
        <xref rid="aff2" ref-type="aff">‡</xref>
      </contrib>
      <contrib contrib-type="author" id="ath3">
        <name>
          <surname>van der Schaar</surname>
          <given-names>Mihaela</given-names>
        </name>
        <xref rid="aff3" ref-type="aff">§</xref>
        <xref rid="aff4" ref-type="aff">∥</xref>
      </contrib>
      <contrib contrib-type="author" corresp="yes" id="ath4">
        <name>
          <surname>Deane</surname>
          <given-names>Charlotte M.</given-names>
        </name>
        <xref rid="cor1" ref-type="other">*</xref>
        <xref rid="aff1" ref-type="aff">†</xref>
      </contrib>
      <aff id="aff1"><label>†</label>Oxford
Protein Informatics Group, Department of Statistics, <institution>University of Oxford</institution>, Oxford OX1 3LB, <country>U.K.</country></aff>
      <aff id="aff2"><label>‡</label><institution>Exscientia
Ltd</institution>, 36 St. Giles’, Oxford OX1 3LD, <country>U.K.</country></aff>
      <aff id="aff3"><label>§</label><institution>University
of Cambridge</institution>, Cambridge CB2 1PZ, <country>U.K.</country></aff>
      <aff id="aff4"><label>∥</label><institution>Alan
Turing Institute</institution>, London NW1 2DB, <country>U.K.</country></aff>
    </contrib-group>
    <author-notes>
      <corresp id="cor1"><label>*</label>E-mail: <email>deane@stats.ox.ac.uk</email>.</corresp>
    </author-notes>
    <pub-date pub-type="epub">
      <day>20</day>
      <month>03</month>
      <year>2020</year>
    </pub-date>
    <pub-date pub-type="ppub">
      <day>27</day>
      <month>04</month>
      <year>2020</year>
    </pub-date>
    <volume>60</volume>
    <issue>4</issue>
    <fpage>1983</fpage>
    <lpage>1995</lpage>
    <history>
      <date date-type="received">
        <day>03</day>
        <month>12</month>
        <year>2019</year>
      </date>
    </history>
    <permissions>
      <copyright-statement>Copyright © 2020 American Chemical
Society</copyright-statement>
      <copyright-year>2020</copyright-year>
      <copyright-holder>American Chemical
Society</copyright-holder>
      <license>
        <license-p>This is an open access article published under a Creative Commons Attribution (CC-BY) <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/page/policy/authorchoice_ccby_termsofuse.html">License</ext-link>, which permits unrestricted use, distribution and reproduction in any medium, provided the author and source are cited.</license-p>
      </license>
    </permissions>
    <abstract>
      <p content-type="toc-graphic">
        <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ci9b01120_0007" id="ab-tgr1"/>
      </p>
      <p>Rational compound design remains
a challenging problem for both
computational methods and medicinal chemists. Computational generative
methods have begun to show promising results for the design problem.
However, they have not yet used the power of three-dimensional (3D)
structural information. We have developed a novel graph-based deep
generative model that combines state-of-the-art machine learning techniques
with structural knowledge. Our method (“DeLinker”) takes
two fragments or partial structures and designs a molecule incorporating
both. The generation process is protein-context-dependent, utilizing
the relative distance and orientation between the partial structures.
This 3D information is vital to successful compound design, and we
demonstrate its impact on the generation process and the limitations
of omitting such information. In a large-scale evaluation, DeLinker
designed 60% more molecules with high 3D similarity to the original
molecule than a database baseline. When considering the more relevant
problem of longer linkers with at least five atoms, the outperformance
increased to 200%. We demonstrate the effectiveness and applicability
of this approach on a diverse range of design problems: fragment linking,
scaffold hopping, and proteolysis targeting chimera (PROTAC) design.
As far as we are aware, this is the first molecular generative model
to incorporate 3D structural information directly in the design process.
The code is available at <uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://github.com/oxpig/DeLinker">https://github.com/oxpig/DeLinker</uri>.</p>
    </abstract>
    <custom-meta-group>
      <custom-meta>
        <meta-name>document-id-old-9</meta-name>
        <meta-value>ci9b01120</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>document-id-new-14</meta-name>
        <meta-value>ci9b01120</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>ccc-price</meta-name>
        <meta-value/>
      </custom-meta>
    </custom-meta-group>
  </article-meta>
</front>
<body>
  <sec id="sec1">
    <title>Introduction</title>
    <p>Drug design is an iterative
process that requires potential compounds
to be optimized for specific properties, ranging from binding affinity
to pharmacokinetics. This process is challenging, in part, due to
the size of the search space<sup><xref ref-type="bibr" rid="ref1">1</xref></sup> and discontinuous
nature of the optimization landscape.<sup><xref ref-type="bibr" rid="ref2">2</xref></sup> Typically,
molecule design is undertaken by human experts and therefore is a
subjective process.</p>
    <p>Machine learning models for molecule generation
have been proposed
as an alternative to human-led design and rule-based transformations.<sup><xref ref-type="bibr" rid="ref3">3</xref>−<xref ref-type="bibr" rid="ref5">5</xref></sup> Generative models have adopted either the SMILES string representation
of molecules<sup><xref ref-type="bibr" rid="ref6">6</xref>−<xref ref-type="bibr" rid="ref10">10</xref></sup> or, more recently, graph representations.<sup><xref ref-type="bibr" rid="ref11">11</xref>−<xref ref-type="bibr" rid="ref16">16</xref></sup> Existing generative models have primarily been used in two ways.
First, methods have been developed to generate molecules that follow
the same distribution as the training set, whether a general set of
molecules<sup><xref ref-type="bibr" rid="ref10">10</xref></sup> such as ZINC<sup><xref ref-type="bibr" rid="ref17">17</xref></sup> or ChEMBL,<sup><xref ref-type="bibr" rid="ref18">18</xref></sup> or a more focused
one such as inhibitors for a particular protein target.<sup><xref ref-type="bibr" rid="ref7">7</xref>,<xref ref-type="bibr" rid="ref19">19</xref></sup> Second, generative models have been proposed to perform molecular
optimization, taking an input molecule and attempting to modify one
or several chemical properties, typically subject to a similarity
constraint.<sup><xref ref-type="bibr" rid="ref16">16</xref>,<xref ref-type="bibr" rid="ref20">20</xref>,<xref ref-type="bibr" rid="ref21">21</xref></sup></p>
    <p>While substantial progress has been made for these two problems,
current methods have inherent limitations, in particular, for structure-based
design. Only one approach to date has attempted to include any three-dimensional
(3D) information in the generative process,<sup><xref ref-type="bibr" rid="ref22">22</xref></sup> despite its importance for designing potent and selective compounds.
In this work, Skalic et al.<sup><xref ref-type="bibr" rid="ref22">22</xref></sup> proposed
a SMILES-based model for generating molecules from 3D representations.<sup><xref ref-type="bibr" rid="ref22">22</xref></sup> A shape variational autoencoder using convolutional
neural networks (CNNs) was coupled with a shape captioning network
consisting of a separate CNN used to condition a recurrent neural
network (RNN). In this formulation, 3D information was only provided
implicitly to seed the RNN, and the method did not allow further control
over generated compounds. As a result, their generative model frequently
changed the entire molecule and recovered fewer than 2% of the seed
molecules. This is undesirable in many practical settings, such as
the design problems described below.</p>
    <p>Fragment-based drug discovery
(FBDD) has become an increasingly
important tool for finding hit compounds, in particular, for challenging
targets and novel protein families. FBDD utilizes smaller than drug-like
compounds (typically &lt;300 Da) to identify low potency, high-quality
leads, which are then matured into more potent, drug-like compounds.
One common way of maturing fragment hits is through a linking strategy,
joining fragments together that bind to distinct sites via a linker.
It is crucial for successful fragment linking that a linker does not
disturb the original binding poses of each fragment.<sup><xref ref-type="bibr" rid="ref23">23</xref>,<xref ref-type="bibr" rid="ref24">24</xref></sup> Thus, compound suggestions have strong 3D constraints, determined
by the binding mode of the fragments.</p>
    <p>Scaffold hopping, though
a distinct problem, shares some characteristics
with fragment linking. The aim of scaffold hopping is to discover
structurally novel compounds starting from a known active compound
by modifying the central core structure of the molecule.<sup><xref ref-type="bibr" rid="ref25">25</xref></sup> Such a change can result in much improved molecular
properties, such as solubility, toxicity, synthetic accessibility,
affinity, and selectivity.<sup><xref ref-type="bibr" rid="ref25">25</xref>,<xref ref-type="bibr" rid="ref26">26</xref></sup></p>
    <p>Numerous computational
methods have been proposed for fragment
linking or scaffold hopping.<sup><xref ref-type="bibr" rid="ref27">27</xref>−<xref ref-type="bibr" rid="ref32">32</xref></sup> However, almost all methods published to date rely exclusively on
a database of candidate fragments from which to select a linker, with
the differences between approaches arising solely from how the database
is searched, how the linked compounds are scored, or the contents
of the database itself. As a result, these methods are inherently
constrained to a set of predetermined rules or examples, limiting
exploration of chemical space. In addition, they can only incorporate
additional structural knowledge (e.g., the fragment’s binding
mode) via filtering or search mechanisms.</p>
    <p>Current machine-learning-based
molecule generation methods have
not been designed to effectively handle the structure-based design
tasks of fragment linking and scaffold hopping. These scenarios require
proposed molecules to contain specific substructures, with the goal
to design a molecule that maintains the binding mode of the original
compound or fragments.</p>
    <p>Numerous challenges using SMILES-based
methods have been previously
noted, largely arising from using language to represent inherently
graph-based objects.<sup><xref ref-type="bibr" rid="ref12">12</xref>,<xref ref-type="bibr" rid="ref33">33</xref></sup> In particular, the grammar makes
working with existing structures especially difficult and has even
led to alternative language-based representations being proposed.<sup><xref ref-type="bibr" rid="ref34">34</xref>,<xref ref-type="bibr" rid="ref35">35</xref></sup> We therefore do not believe that design tasks requiring proposed
molecules to contain specific substructures naturally suit a SMILES-based
representation, although this remains an active area of research.<sup><xref ref-type="bibr" rid="ref36">36</xref></sup></p>
    <p>Graph-based methods have become more widely
used, in particular,
for molecular optimization.<sup><xref ref-type="bibr" rid="ref16">16</xref>,<xref ref-type="bibr" rid="ref20">20</xref>,<xref ref-type="bibr" rid="ref21">21</xref></sup> Due to the nature of these tasks, the shapes of the suggested molecules
often differ greatly from the starting points, and many of the proposed
changes are R-group modifications. In addition, most methods do not
afford a high level of control over the generated molecule. Li et
al.<sup><xref ref-type="bibr" rid="ref37">37</xref></sup> recently proposed a scaffold-based
molecular generator that designs molecules retaining particular scaffolds
as their core structures.<sup><xref ref-type="bibr" rid="ref37">37</xref></sup> This allows
greater control over generated molecules than most existing methods.
However, none of the graph-based methods to date incorporate 3D structural
information, with only one SMILES-based approach, including any 3D
information in the generative process.<sup><xref ref-type="bibr" rid="ref22">22</xref></sup></p>
    <p>Finally, Ståhl et al.<sup><xref ref-type="bibr" rid="ref38">38</xref></sup> introduced
a fragment-based reinforcement learning approach for multiparameter
optimization.<sup><xref ref-type="bibr" rid="ref38">38</xref></sup> At each step, their model
selects a fragment contained in the molecule and replaces it with
a similar one. This typically leads to minor changes in the compounds
and could be utilized for scaffold hopping. However, their model is
not able to perform fragment linking and is not designed for tasks
requiring 3D shape optimization.</p>
    <p>In this work, we introduce
the first graph-based deep generative
method that incorporates 3D structural information directly into the
design process. Our method takes as input two molecular fragments
and designs a molecule incorporating both substructures, either generating
or replacing the linker between them. This allows our method to handle
structure-based design tasks such as fragment linking and scaffold
hopping effectively. The generation process integrates 3D structural
information, specifically the distance between the fragments and their
relative orientations. This 3D information is vital to successful
compound design, and we demonstrate the limitations of omitting such
information, both quantifying its impact in large-scale assessments
and empirically showing how our model uses the structural information.</p>
    <p>We first demonstrate the effectiveness of our proposed deep generative
approach over a database method through large-scale computational
assessments. We show that our method, DeLinker, designs 60% more compounds
with high 3D similarity to the original molecule compared to a database-based
approach on an independent test set. DeLinker outperforms the database
approach by 200% when the evaluation is restricted to linkers with
at least five atoms. We then apply our method to several case studies
encompassing fragment linking, scaffold hopping, and PROTAC design.
DeLinker frequently recovers the experimental end point, even in cases
where the linker was not present in the training set, and produces
many novel designs with high 3D similarity to the original molecules.</p>
  </sec>
  <sec id="sec2">
    <title>Methods</title>
    <p>The method takes two fragments and their relative position and
orientation and generates or replaces the linker between them. This
is achieved by building new molecules in an iterative manner “bond
by bond” from a pool of atoms that can be initialized with
partial structures (<xref rid="fig1" ref-type="fig">Figure <xref rid="fig1" ref-type="fig">1</xref></xref>). In this framework, the user is able to control the generation
process by specifying both the substructures that should be linked
and the maximum length of the linker between them. The starting substructures
are always retained in the generated molecule, with changes only from
the specified exit vectors. In addition, 3D structural information
in the form of the distance and angle between the starting substructures
is provided to the model to inform the design process. Molecules are
encoded by a set of 14 permitted atom types, and our model enforces
simple atomic valency rules via a masking procedure to ensure chemical
validity. This is the only chemical knowledge incorporated directly
into our model; all other decisions required to generate molecules
are learnt through a supervised training procedure.</p>
    <fig id="fig1" position="float">
      <label>Figure 1</label>
      <caption>
        <p>Overview of the generation
process. The initial fragments (a) are
iteratively expanded bond by bond (c–e) to produce a molecule,
including both fragments (f). Atoms are represented by nodes in a
graph, with the color of the nodes representing different atom types,
while bonds are represented by edges, with different edge types for
single, double, and triple bonds.</p>
      </caption>
      <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ci9b01120_0008" id="gr1" position="float"/>
    </fig>
    <sec id="sec2.1">
      <title>Generative
Process</title>
      <p>The generative process is illustrated
in <xref rid="fig1" ref-type="fig">Figure <xref rid="fig1" ref-type="fig">1</xref></xref> and is
similar to Liu et al.,<sup><xref ref-type="bibr" rid="ref14">14</xref></sup> in that our method
builds molecules bond by bond in a breadth-first manner. Generation
is initialized with two fragments or substructures that are to be
linked together with structural information providing the distance
and angle between the substructures. The fragments are converted to
a graph representation, where atoms and bonds are represented by nodes
and edges, respectively. Each node is associated with a hidden state, <bold>z</bold><italic><sub>v</sub></italic>, and label, <bold>l</bold><italic><sub>v</sub></italic>, representing the atom type of the node. A
list of the 14 permitted atom types can be found in the <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/acs.jcim.9b01120/suppl_file/ci9b01120_si_002.pdf">Supporting Information</ext-link>. The graph is passed through
an encoder network, a standard gated graph neural network (GGNN),<sup><xref ref-type="bibr" rid="ref39">39</xref></sup> and the hidden states of the nodes are updated
to incorporate their local environment (<xref rid="fig1" ref-type="fig">Figure <xref rid="fig1" ref-type="fig">1</xref></xref>a).</p>
      <p>Next, a set of expansion nodes
are initialized at random, with hidden states <bold>z</bold><italic><sub>v</sub></italic> drawn from the <italic>h</italic>-dimensional
standard normal distribution, <inline-formula id="d30e365"><inline-graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ci9b01120_m001.gif"/></inline-formula>, where <italic>h</italic> is the
length
of the hidden state (<xref rid="fig1" ref-type="fig">Figure <xref rid="fig1" ref-type="fig">1</xref></xref>b). The nodes are then labeled with an atom type according
to their hidden state, <bold>z</bold><italic><sub>v</sub></italic>, and the structural information by sampling from the softmax output
of a learned mapping <italic>f</italic>. Here, <italic>f</italic> is
implemented as a linear classifier but could be any function mapping
a node’s hidden state to an atom type. The number of expansion
nodes determines the maximum length of the linker and is a parameter
chosen by the user.</p>
      <p>The new molecule is constructed from this
set of nodes via an iterative
process consisting of edge selection, edge labeling, and node update
(<xref rid="fig1" ref-type="fig">Figure <xref rid="fig1" ref-type="fig">1</xref></xref>c–e).
At each step, we consider whether to add an edge between one of the
nodes, <italic>v</italic>, and another node in the graph. <italic>v</italic> is chosen according to a deterministic first-in-first-out
queue that is initialized with the exit vectors of each fragment.
When a node is connected to the graph for the first time, it is added
to the queue. New edges are added to node <italic>v</italic> until
an edge to the stop node is selected. The node then becomes “closed”
with no additional edges with that node permitted.</p>
      <p>All possible
edges between the node <italic>v</italic> and other
nodes in the graph are considered (<xref rid="fig1" ref-type="fig">Figure <xref rid="fig1" ref-type="fig">1</xref></xref>c), subject to basic valency constraints.
A single-layer neural network assesses the candidate edges using a
feature vector. The feature vector for the edge between node <italic>v</italic> and candidate node <italic>u</italic> is given by<disp-formula id="ueq1"><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ci9b01120_m002" position="anchor"/></disp-formula>where <bold>s</bold><sub><italic>v</italic></sub><sup arrange="stack"><italic>t</italic></sup> = [<bold>z</bold><sub><italic>v</italic></sub><sup arrange="stack"><italic>t</italic></sup>, <bold>l</bold><sub><italic>v</italic></sub>] is
the concatenation of the hidden state of node <italic>v</italic> after <italic>t</italic> steps and its atomic label, <italic>d</italic><sub><italic>v</italic>,<italic>u</italic></sub> is the
graph distance between <italic>v</italic> and <italic>u</italic>, <bold>H</bold><sup>0</sup> is the average initial representation of all
nodes, <bold>H</bold><sup><italic>t</italic></sup> is the average
representation of nodes at generation step <italic>t</italic>, and <bold>D</bold> represents the 3D structural information.</p>
      <p>As such,
when choosing which edge to add to the graph, the model
utilizes (1) local information about the nodes, (2) global information
regarding the unlinked fragments and the current graph state, and
(3) 3D structural information.</p>
      <p>Once a node <italic>u</italic> has been selected, the edge between <italic>v</italic> and <italic>u</italic> is labeled as either a single,
double, or triple bond (subject to valency constraints) by another
single-layer neural network taking as input the same feature vector
ϕ<sub><italic>v</italic>,<italic>u</italic></sub><sup arrange="stack"><italic>t</italic></sup> (<xref rid="fig1" ref-type="fig">Figure <xref rid="fig1" ref-type="fig">1</xref></xref>d).</p>
      <p>Finally, the hidden states of all
nodes are updated according to
a GGNN (<xref rid="fig1" ref-type="fig">Figure <xref rid="fig1" ref-type="fig">1</xref></xref>e).
At each step, we discard the current hidden states <inline-formula id="d30e520"><inline-graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ci9b01120_m003.gif"/></inline-formula> and compute new representations <inline-formula id="d30e523"><inline-graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ci9b01120_m004.gif"/></inline-formula>, taking their (possibly changed) neighborhood
into account. Note that <inline-formula id="d30e526"><inline-graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ci9b01120_m005.gif"/></inline-formula> is computed from <inline-formula id="d30e529"><inline-graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ci9b01120_m006.gif"/></inline-formula> rather than <inline-formula id="d30e533"><inline-graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ci9b01120_m007.gif"/></inline-formula>. This means that the state
of each node
is independent of the generation history of the graph and depends
only on the current state of the graph.</p>
      <p>Steps c–e in <xref rid="fig1" ref-type="fig">Figure <xref rid="fig1" ref-type="fig">1</xref></xref> are repeated for
each node in the queue, until the queue
is empty, at which point the generation process terminates. At termination
(<xref rid="fig1" ref-type="fig">Figure <xref rid="fig1" ref-type="fig">1</xref></xref>f), all unconnected
nodes are removed and the largest connected component is returned
as the generated molecule. We note that the stereochemistry of generated
molecules is not assigned during the generative process.</p>
    </sec>
    <sec id="sec2.2">
      <title>Multimodal
Encoder–Decoder Setup</title>
      <p>Our goal is
to learn a multimodal mapping from unconnected fragments to connected
molecules. During training, we utilized a data set of paired fragments
and molecules and trained our model in a supervised manner to reconstruct
known linkers. While in this data set there may be a unique molecule
associated with two fragments, in practice, there are many ways to
link two fragments. As such, given a new pair of starting points,
a model should be able to generate a diverse set of output compounds.</p>
      <p>To this end, we took inspiration from Jin et al.<sup><xref ref-type="bibr" rid="ref16">16</xref></sup> and augmented the basic encoder–decoder model with
a low-dimensional latent vector <bold>z</bold> to explicitly encode
the multimodal aspect of the distribution of suitable linkers. The
generative mapping is converted from <italic>F</italic>: <italic>X</italic> → <italic>Y</italic> to <italic>F</italic>: (<italic>X</italic>, <bold>z</bold>) → <italic>Y</italic>, where <italic>X</italic> represents the starting substructures and <italic>Y</italic> the
connected molecule, with latent code <bold>z</bold> drawn from a prior
distribution, chosen to be the standard normal distribution, <inline-formula id="d30e590"><inline-graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ci9b01120_m008.gif"/></inline-formula>.</p>
      <p>There are two challenges
in learning this mapping. First, as shown
in the image domain,<sup><xref ref-type="bibr" rid="ref40">40</xref></sup> the latent codes
are often ignored by the model unless they are forced to encode meaningful
variations. Second, the latent codes should be suitably regularized
so that the model does not produce invalid outputs. That is, the generated
molecule <italic>F</italic>(<italic>X</italic>, <bold>z</bold>) should
belong to the domain of the target molecule <italic>Y</italic> (i.e.,
connected and able to satisfy the structural constraints provided)
given a latent code drawn from the prior distribution. We overcame
both of these challenges through our training procedure, where we
derived <bold>z</bold> during training from the embedding of the linked
molecule, but regularized the latent vector to follow a standard normal
distribution so that we can sample <bold>z</bold> during generation.</p>
    </sec>
    <sec id="sec2.3">
      <title>Training</title>
      <p>We trained our generative model under a variational
autoencoder (VAE) framework on a collection of fragment–molecule
pairs (<xref rid="fig2" ref-type="fig">Figure <xref rid="fig2" ref-type="fig">2</xref></xref>). For
a given pair of fragments <italic>X</italic> and linked molecule <italic>Y</italic>, the model is trained to reconstruct <italic>Y</italic> from (<italic>X</italic>, <bold>z</bold>), while enforcing the standard
regularization constraint on both <bold>z</bold> and the encoding
of <italic>X</italic>, <bold>z</bold><sub><italic>X</italic></sub> ≔ {<bold>z</bold><sub><italic>v</italic></sub>: <italic>v</italic> ∈ <italic>X</italic>}.</p>
      <fig id="fig2" position="float">
        <label>Figure 2</label>
        <caption>
          <p>Illustration of training and generation
procedures. (a) Pairs of
fragments and linked molecules are provided as input. The model is
trained to reproduce the linked molecule from a combination of the
encodings of the fragments and linked molecule. (b) At generation
time, the model is given only the unlinked fragments and structural
information and is able to sample a diverse range of linked molecules
by combining the encoding of the fragments with random noise.</p>
        </caption>
        <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ci9b01120_0005" id="gr2" position="float"/>
      </fig>
      <p>To encode meaningful variations, the latent code <bold>z</bold> is derived via a learnt mapping from the average of the
node embeddings
of the ground truth molecule <italic>Y</italic>, the linked molecule.
Crucially, <bold>z</bold> is constrained to be a low-dimensional vector
to prevent the model from ignoring input <italic>X</italic> and degenerating
to an autoencoder for <italic>Y</italic>. The decoder is trained to
reconstruct <italic>Y</italic> when taking as input a combination
of the low-dimensional vector <bold>z</bold> and the node embeddings <bold>z</bold><sub><italic>X</italic></sub> of the unlinked fragments <italic>X</italic> (<xref rid="fig2" ref-type="fig">Figure <xref rid="fig2" ref-type="fig">2</xref></xref>).</p>
      <p>The training objective is similar to the standard VAE loss,
including
a reconstruction loss and a Kullback–Leibler (KL) regularization
term<disp-formula id="ueq2"><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ci9b01120_m009" position="anchor"/></disp-formula>The reconstruction loss, <inline-formula id="d30e716"><inline-graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ci9b01120_m010.gif"/></inline-formula>, is composed of two cross-entropy
loss
terms, resulting from the error in predicting the atom types and in
reconstructing the sequence of steps required to produce the target
molecule.</p>
      <p>The KL regularization loss, <inline-formula id="d30e721"><inline-graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ci9b01120_m011.gif"/></inline-formula>, contains
two terms, one for the encoding
of the unlinked fragments, <italic>X</italic>, and the other for the
low-dimensional vector <bold>z</bold> derived from the linked molecule <italic>Y</italic>. These terms are the standard VAE terms capturing the
KL divergence between the encoder distributions and the standard Gaussian
prior.</p>
      <p>We performed limited hyperparameter tuning, measuring
performance
via the validation loss and not generative performance directly. We
found that overall the model was fairly robust to the choice of hyperparameters.
Full details of the model architecture and hyperparameters can be
found in the <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/acs.jcim.9b01120/suppl_file/ci9b01120_si_002.pdf">Supporting Information</ext-link>.</p>
    </sec>
    <sec id="sec2.4">
      <title>Data Sets</title>
      <p>There have only been a limited number of
examples of successful fragment linking or scaffold hopping reported.
As such, for training and large-scale evaluation, we constructed sets
of fragment–molecule pairs using standard transformations from
matched-molecular pair analysis.<sup><xref ref-type="bibr" rid="ref5">5</xref></sup></p>
    </sec>
    <sec id="sec2.5">
      <title>ZINC</title>
      <p>To construct our training set, we used the subset
of ZINC<sup><xref ref-type="bibr" rid="ref17">17</xref></sup> selected at random by Gómez-Bombarelli
et al.<sup><xref ref-type="bibr" rid="ref10">10</xref></sup> that contains 250 000 molecules.
We constructed possible fragmentations of each molecule by enumerating
all double cuts of acyclic single bonds that were not within functional
groups, the same procedure adopted by Hussain and Rea.<sup><xref ref-type="bibr" rid="ref5">5</xref></sup> Fragmentations satisfying basic criteria regarding the
number of atoms in the linker and fragments were retained, removing
trivial and unrealistic scenarios (see the <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/acs.jcim.9b01120/suppl_file/ci9b01120_si_002.pdf">Supporting Information</ext-link> for further details).</p>
      <p>The remaining fragment–molecule
pairs were filtered for several two-dimensional (2D) properties, namely,
synthetic accessibility,<sup><xref ref-type="bibr" rid="ref41">41</xref></sup> ring aromaticity,
and pan-assay interference compounds (PAINS),<sup><xref ref-type="bibr" rid="ref42">42</xref></sup> to remove unwanted examples. Full details of the property filters
can be found in the <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/acs.jcim.9b01120/suppl_file/ci9b01120_si_002.pdf">Supporting Information</ext-link>.</p>
      <p>By filtering the training set for specific 2D properties,
we are
also able to assess whether the model is able to learn to generate
linkers with certain properties implicitly from the data alone. Since
these properties are not input explicitly into the model, these could
easily be tailored to a specific project or other requirements.</p>
      <p>To provide structural information, we generated 3D conformers for
the ZINC set using RDKit,<sup><xref ref-type="bibr" rid="ref43">43</xref></sup> adopting the
filtering and sampling procedure proposed by Ebejer et al.<sup><xref ref-type="bibr" rid="ref44">44</xref></sup> We took the lowest-energy conformation as the
reference 3D structure for each molecule.</p>
      <p>These preprocessing
and filtering steps resulted in a data set
of 418 797 example fragment elaborations, with linkers of between
3 and 12 atoms. We selected 800 fragment–molecule pairs at
random for model validation (400) and testing (400) and used the remainder
to train our model, ensuring no overlap between the molecules in the
training and held-out sets.</p>
    </sec>
    <sec id="sec2.6">
      <title>CASF</title>
      <p>A major limitation of the ZINC
data set is the
use of generated conformers, as opposed to experimentally verified
active ones. To address this, we used the CASF-2016 data set,<sup><xref ref-type="bibr" rid="ref45">45</xref></sup> also known as the PDBbind core set, which consists
of 285 protein–ligand complexes from PDBbind with high-quality
crystal structures from a diverse set of proteins, as an independent
test set. We followed the same preprocessing procedure as for the
ZINC data set (except for conformer generation), resulting in a set
of 309 examples.</p>
      <p>We performed large-scale evaluations of our
method on both the held-out ZINC test data and the CASF data set.
For each example, we generated 250 molecules from each pair of unlinked
fragments, assuming that the linker length was equal to the linker
length of the original molecule.</p>
    </sec>
    <sec id="sec2.7">
      <title>Assessment Metrics</title>
      <p>We assessed the generated molecules
with a range of 2D and 3D metrics. As is standard in the assessment
of models for molecule generation,<sup><xref ref-type="bibr" rid="ref46">46</xref></sup> we
first checked the generated molecules for validity, uniqueness, and
novelty. We then determined if the generated linkers were consistent
with the 2D property filters used to produce the training set. In
addition, we recorded in how many cases the original molecule used
to produce the fragments was recovered by the generation process.</p>
      <p>Molecules that passed the 2D property filters were assessed on the
basis of their 3D shape. Conformers of the generated molecules and
the original molecule were compared using two distinct methods: (i)
a shape and color similarity score (SC<sub>RDKit</sub>) and (ii) root-mean-square
deviation (RMSD).</p>
      <p>The shape and color similarity score (SC<sub>RDKit</sub>) uses
two RDKit functions, based on the methods described in Putta et al.<sup><xref ref-type="bibr" rid="ref47">47</xref></sup> and Landrum et al.<sup><xref ref-type="bibr" rid="ref48">48</xref></sup> The color similarity function scores two 3D conformers against each
other based on the overlap of their pharmacophoric features, while
the shape similarity measure is a simple volumetric comparison between
the two conformers. Each produces a score between 0 (no match) and
1 (perfect match), which are averaged to produce a final score between
0 and 1. Scores above 0.7 indicate a good match, while scores above
0.9 suggest an almost perfect match. An illustration of several conformers
and their similarity scores can be seen in <xref rid="fig3" ref-type="fig">Figure <xref rid="fig3" ref-type="fig">3</xref></xref>.</p>
      <fig id="fig3" position="float">
        <label>Figure 3</label>
        <caption>
          <p>Examples of the 3D metrics used to assess the
similarity of conformers.
The reference conformer is shown in magenta, while conformers of the
generated molecule are shown in cyan. (a) Represents very strong alignment
by both fragment-based metrics but lower similarity by SC<sub>RDKit</sub> Molecule due to the different linker. (b) Shows modest similarity
by all three metrics, while (c) represents poor similarity by all
three measures.</p>
        </caption>
        <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ci9b01120_0006" id="gr3" position="float"/>
      </fig>
      <p>SC<sub>RDKit</sub> can either
be calculated by comparing only the
atoms of the starting fragments (SC<sub>RDKit</sub> Fragments) or
by comparing the entire generated molecule to the original molecule
(SC<sub>RDKit</sub> Molecule). The first measure assesses how closely
the conformations of the fragments match, whereas the second also
incorporates whether the generated linker matches the original (<xref rid="fig3" ref-type="fig">Figure <xref rid="fig3" ref-type="fig">3</xref></xref>). Our method is
trained to output a diverse range of linkers and not to map exactly
to a previously observed linker. However, in the case of scaffold
hopping, this metric is important as typically the new linker should
match the shape and pharmacophoric features of the original core.<sup><xref ref-type="bibr" rid="ref26">26</xref></sup></p>
      <p>RMSD between the coordinates of atoms
in the starting fragments
in the original and generated molecules can be calculated to give
a different measure of 3D similarity (RMSD Fragments). A perfect match
has an RMSD of 0 Å, with a higher figure indicating greater deviation.
An RMSD of below 0.5 Å suggests an almost perfect match, while
an RMSD of above 1.0 Å corresponds to a poor match given the
alignment procedure and number of heavy atoms. An illustration of
several conformations and their RMSDs can be seen in <xref rid="fig3" ref-type="fig">Figure <xref rid="fig3" ref-type="fig">3</xref></xref>. Due to the need to match
specific atoms, RMSD can only be (reliably) calculated between the
atoms of the fragments that are linked and not the entire molecule.</p>
      <p>For each proposed molecule, we generated 3D conformers using RDKit,<sup><xref ref-type="bibr" rid="ref43">43</xref></sup> adopting the filtering and sampling procedure
proposed by Ebejer et al.,<sup><xref ref-type="bibr" rid="ref44">44</xref></sup> and scored
all conformers. The score for each similarity measure was the best
score among all generated conformers for a particular molecule.</p>
    </sec>
    <sec id="sec2.8">
      <title>Comparison to Other Methods</title>
      <p>Several traditional methods
exist for linking fragments or replacing the core of a molecule.<sup><xref ref-type="bibr" rid="ref27">27</xref>−<xref ref-type="bibr" rid="ref32">32</xref></sup> Almost all methods rely on a database from which to select linkers.
As a baseline with which to compare our method, we created a set of
all linkers from the training data and sampled from this set, joining
the linker in one of the two possible orientations at random. This
setup ensures that both methods are constructed using the same data
and allows us to assess whether the generated molecules have better
shape complementarity than using linkers from the database, while
still obeying 2D chemical constraints.</p>
      <p>Liu et al.<sup><xref ref-type="bibr" rid="ref14">14</xref></sup> proposed constrained graph variational autoencoders
to generate molecular graphs. They sought to generate arbitrary molecules
that conformed to the distribution observed in the training data.
Similar to our method, they assumed a sequential ordering of graph
extension steps, constructing molecules in a bond-by-bond manner.
To compare their work to our method, it was necessary to modify their
implementation to perform the molecular design tasks described.</p>
      <p>Our work differs from the model of Liu et al.<sup><xref ref-type="bibr" rid="ref14">14</xref></sup> in three key ways. First, our model takes as input structural
information in the form of the distance and angle between the starting
substructures and uses this to augment the feature vector used in
the generation process. Second, our model is designed to be trained
for molecular translation, in particular, taking as input unlinked
substructures and generating linked molecules. While others have developed
methods for molecular translation,<sup><xref ref-type="bibr" rid="ref16">16</xref>,<xref ref-type="bibr" rid="ref21">21</xref></sup> none have
taken two unlinked substructures as input. Third, we have modified
the training procedure from a standard encoder–decoder framework
to explicitly encode the set of possible linkers. The training process
combines encodings of both the unlinked substructures and the linked
molecule, as opposed to solely the starting point (<xref rid="fig2" ref-type="fig">Figure <xref rid="fig2" ref-type="fig">2</xref></xref>). In addition, there are several
minor architectural differences between DeLinker and their model (further
details can be found in the <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/acs.jcim.9b01120/suppl_file/ci9b01120_si_002.pdf">Supporting Information</ext-link>). The impact of these changes is detailed in <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/acs.jcim.9b01120/suppl_file/ci9b01120_si_002.pdf">Tables S2</ext-link> and <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/acs.jcim.9b01120/suppl_file/ci9b01120_si_002.pdf">S3</ext-link>.</p>
    </sec>
    <sec id="sec2.9">
      <title>Experimental
Setup</title>
      <p>In all of our experiments, we used
the same training set derived from the ZINC data set to train DeLinker
and construct the database for the Database baseline. In both of the
large-scale evaluations on the held-out ZINC test data and the CASF
data set, we generated 250 linkers for each pair of starting fragments
to be assessed for both DeLinker and the Database. The number of atoms
in the linker was set equal to the linker length of the original molecule
for both DeLinker and the Database baseline in each of the large-scale
evaluations. We also demonstrated the applicability of DeLinker using
case studies from fragment linking, scaffold hopping, and PROTAC design.
There are minor differences in the evaluation of our generative method
for the case studies. These deviations are detailed in the <xref rid="sec3" ref-type="other">Results and Discussion</xref> section with the appropriate
case study.</p>
      <p>Generated molecules were first assessed by the 2D
metrics described above. Molecules that passed the 2D property filters
were assessed on the basis of their 3D shape, as described above.
We reported the proportion of molecules that pass the 2D metrics that
meet 3D similarity thresholds.</p>
    </sec>
  </sec>
  <sec id="sec3">
    <title>Results and Discussion</title>
    <p>We demonstrate DeLinker, a deep generative method that designs
a molecule incorporating two starting substructures using 3D structural
information. We first checked the impact of the structural information
and then assessed our generative method in three experiments: (i)
large-scale validation on ZINC (generated conformers), (ii) large-scale
validation on CASF (experimentally determined active conformations),
and (iii) three case studies covering fragment linking,<sup><xref ref-type="bibr" rid="ref49">49</xref></sup> scaffold hopping,<sup><xref ref-type="bibr" rid="ref50">50</xref></sup> and PROTAC design.<sup><xref ref-type="bibr" rid="ref51">51</xref></sup></p>
    <sec id="sec3.1">
      <title>Importance of Structural
Information</title>
      <p>To assess the
importance of including structural information, we empirically examined
its impact on the generation process (<xref rid="tbl1" ref-type="other">Table <xref rid="tbl1" ref-type="other">1</xref></xref>). We considered three almost identical fragment–molecule
pairs based on ZINC7670105 from the held-out ZINC test set (see <xref rid="sec2" ref-type="other">Methods</xref>). In all three cases, the starting substructures
remained constant, but the substitution pattern of the benzene linker
differed. This resulted in the distance and angle between the fragments
changing but no other differences between the input data to our model.
We generated 1000 linkers with a maximum of six atoms for each set
of structural information and assessed the substitution pattern of
generated molecules that contained a six-membered ring as the linker
(<xref rid="tbl1" ref-type="other">Table <xref rid="tbl1" ref-type="other">1</xref></xref>).</p>
      <table-wrap id="tbl1" position="float">
        <label>Table 1</label>
        <caption>
          <title>Impact of Structural Information on
Generated Ring Substitution Patterns<xref rid="t1fn1" ref-type="table-fn">a</xref></title>
        </caption>
        <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ci9b01120_0009" id="fx1" position="float"/>
        <table-wrap-foot>
          <fn id="t1fn1">
            <label>a</label>
            <p>The generated
compounds closely
followed the true substitution pattern, with only the structural information
provided differing between examples.</p>
          </fn>
        </table-wrap-foot>
      </table-wrap>
      <p>DeLinker generated a high number of six-membered rings
in all three
cases (33–54%). Most rings were generated with the para structural
information. This is consistent with the chemical knowledge since
there are fewer possibilities given these structural constraints.
The generated molecules closely followed the substitution pattern
of the molecule used to calculate the structural information, with
between 83 and 98% of the rings produced following the same pattern
(<xref rid="tbl1" ref-type="other">Table <xref rid="tbl1" ref-type="other">1</xref></xref>). The effect
of the structural information on the performance of DeLinker in a
large-scale evaluation is discussed below and can be found in <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/acs.jcim.9b01120/suppl_file/ci9b01120_si_002.pdf">Tables S2</ext-link> and <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/acs.jcim.9b01120/suppl_file/ci9b01120_si_002.pdf">S3</ext-link>.</p>
    </sec>
    <sec id="sec3.2">
      <title>Validation on ZINC</title>
      <p>We next evaluated our method on
the held-out test set from the ZINC data set, consisting of 400 pairs
of fragments. We primarily compared DeLinker to a method based on
database lookup (“Database”). The Database samples linkers
from the same set of data used to train our method, joining the fragments
in one of the two possible orientations at random. This setup ensures
that both methods are constructed using the same data and allows a
direct comparison to be made between database lookup and our deep-learning-based
generative approach.</p>
      <p>We generated 250 linkers for each pair
of fragments, resulting in 100 000 generated molecules to be
assessed for both DeLinker and the Database (see <xref rid="sec2" ref-type="other">Methods</xref> for details). For the evaluation of the ZINC test
set, the number of atoms in the linker was set equal to the linker
length of the original molecule. This is an easier test for both methods
than if the linker length was assumed to be unknown but allows us
to assess whether the two methods presented are able to generate molecules
that possess desired 2D chemical properties and high 3D structural
similarity.</p>
      <p>DeLinker generated a high proportion of valid molecules
that passed
the 2D chemical property filters (<xref rid="tbl2" ref-type="other">Table <xref rid="tbl2" ref-type="other">2</xref></xref>) and substantially outperformed the Database
method by all 3D similarity measures (<xref rid="tbl3" ref-type="other">Table <xref rid="tbl3" ref-type="other">3</xref></xref>). DeLinker displayed a similar improvement
over the graph-based molecular generative model of Liu et al.,<sup><xref ref-type="bibr" rid="ref14">14</xref></sup> which performed broadly comparably to the Database
method (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/acs.jcim.9b01120/suppl_file/ci9b01120_si_002.pdf">Tables S2</ext-link> and <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/acs.jcim.9b01120/suppl_file/ci9b01120_si_002.pdf">S3</ext-link>). Further metrics and an ablation study showing the effects
of including different structural information can be found in <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/acs.jcim.9b01120/suppl_file/ci9b01120_si_002.pdf">Tables S2</ext-link> and <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/acs.jcim.9b01120/suppl_file/ci9b01120_si_002.pdf">S3</ext-link>.
Without any structural information, the deep generative model performed
similarly to the Database method by the 3D similarity measures (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/acs.jcim.9b01120/suppl_file/ci9b01120_si_002.pdf">Table S3</ext-link>). Including only the distance between
the fragments substantially improved performance, with further benefit
from including the angle between fragments.</p>
      <table-wrap id="tbl2" position="float">
        <label>Table 2</label>
        <caption>
          <title>2D Performance
Metrics for Molecules
Generated by DeLinker, Our Deep Generative Model, Compared to a Database
Baseline on the Held-Out ZINC Test Set and the Independent CASF Data
Set</title>
        </caption>
        <table frame="hsides" rules="groups" border="0">
          <colgroup>
            <col align="left"/>
            <col align="char" char="."/>
            <col align="char" char="."/>
            <col align="char" char="."/>
            <col align="char" char="."/>
            <col align="char" char="."/>
            <col align="char" char="."/>
          </colgroup>
          <thead>
            <tr>
              <th style="border:none;" align="center"> </th>
              <th colspan="2" align="center" char=".">ZINC<hr/></th>
              <th colspan="2" align="center" char=".">CASF<hr/></th>
              <th colspan="2" align="center" char=".">CASF
≥5 atoms<hr/></th>
            </tr>
            <tr>
              <th style="border:none;" align="left">metric</th>
              <th style="border:none;" align="center" char=".">Database (%)</th>
              <th style="border:none;" align="center" char=".">DeLinker
(%)</th>
              <th style="border:none;" align="center" char=".">Database (%)</th>
              <th style="border:none;" align="center" char=".">DeLinker (%)</th>
              <th style="border:none;" align="center" char=".">Database
(%)</th>
              <th style="border:none;" align="center" char=".">DeLinker (%)</th>
            </tr>
          </thead>
          <tbody>
            <tr>
              <td style="border:none;" align="left">valid</td>
              <td style="border:none;" align="char" char=".">100.0</td>
              <td style="border:none;" align="char" char=".">98.4</td>
              <td style="border:none;" align="char" char=".">99.0</td>
              <td style="border:none;" align="char" char=".">95.5</td>
              <td style="border:none;" align="char" char=".">98.4</td>
              <td style="border:none;" align="char" char=".">94.7</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">unique</td>
              <td style="border:none;" align="char" char=".">38.8</td>
              <td style="border:none;" align="char" char=".">44.2</td>
              <td style="border:none;" align="char" char=".">43.0</td>
              <td style="border:none;" align="char" char=".">51.9</td>
              <td style="border:none;" align="char" char=".">58.3</td>
              <td style="border:none;" align="char" char=".">72.9</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">novel</td>
              <td style="border:none;" align="char" char=".">0.0</td>
              <td style="border:none;" align="char" char=".">39.5</td>
              <td style="border:none;" align="char" char=".">0.0</td>
              <td style="border:none;" align="char" char=".">51.0</td>
              <td style="border:none;" align="char" char=".">0.0</td>
              <td style="border:none;" align="char" char=".">68.7</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">recovered</td>
              <td style="border:none;" align="char" char=".">78.0</td>
              <td style="border:none;" align="char" char=".">79.0</td>
              <td style="border:none;" align="char" char=".">42.8</td>
              <td style="border:none;" align="char" char=".">53.7</td>
              <td style="border:none;" align="char" char=".">14.9</td>
              <td style="border:none;" align="char" char=".">29.8</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">pass 2D filters</td>
              <td style="border:none;" align="char" char=".">97.0</td>
              <td style="border:none;" align="char" char=".">89.8</td>
              <td style="border:none;" align="char" char=".">95.0</td>
              <td style="border:none;" align="char" char=".">81.4</td>
              <td style="border:none;" align="char" char=".">93.6</td>
              <td style="border:none;" align="char" char=".">71.7</td>
            </tr>
          </tbody>
        </table>
      </table-wrap>
      <table-wrap id="tbl3" position="float">
        <label>Table 3</label>
        <caption>
          <title>3D Performance Metrics for Molecules
Generated by DeLinker, Our Deep Generative Model, Compared to a Database
Baseline on the Held-Out ZINC Test Set and the Independent CASF Data
Set<xref rid="t3fn1" ref-type="table-fn">a</xref></title>
        </caption>
        <table frame="hsides" rules="groups" border="0">
          <colgroup>
            <col align="char" char="."/>
            <col align="char" char="."/>
            <col align="char" char="."/>
            <col align="char" char="."/>
            <col align="char" char="."/>
            <col align="char" char="."/>
            <col align="char" char="."/>
          </colgroup>
          <thead>
            <tr>
              <th style="border:none;" align="center" char="."> </th>
              <th colspan="2" align="center" char=".">ZINC<hr/></th>
              <th colspan="2" align="center" char=".">CASF<hr/></th>
              <th colspan="2" align="center" char=".">CASF
≥5 atoms<hr/></th>
            </tr>
            <tr>
              <th style="border:none;" align="left" char=".">metric</th>
              <th style="border:none;" align="center" char=".">Database (%)</th>
              <th style="border:none;" align="center" char=".">DeLinker (%)</th>
              <th style="border:none;" align="center" char=".">Database
(%)</th>
              <th style="border:none;" align="center" char=".">DeLinker (%)</th>
              <th style="border:none;" align="center" char=".">Database (%)</th>
              <th style="border:none;" align="center" char=".">DeLinker
(%)</th>
            </tr>
          </thead>
          <tbody>
            <tr>
              <td colspan="7" style="border:none;" align="left" char=".">SC<sub>RDKit</sub> Molecule</td>
            </tr>
            <tr>
              <td style="border:none;" align="char" char=".">&gt;0.7</td>
              <td style="border:none;" align="char" char=".">33.5</td>
              <td style="border:none;" align="char" char=".">47.1</td>
              <td style="border:none;" align="char" char=".">14.9</td>
              <td style="border:none;" align="char" char=".">22.3</td>
              <td style="border:none;" align="char" char=".">7.8</td>
              <td style="border:none;" align="char" char=".">16.3</td>
            </tr>
            <tr>
              <td style="border:none;" align="char" char=".">&gt;0.8</td>
              <td style="border:none;" align="char" char=".">8.5</td>
              <td style="border:none;" align="char" char=".">14.2</td>
              <td style="border:none;" align="char" char=".">3.3</td>
              <td style="border:none;" align="char" char=".">5.2</td>
              <td style="border:none;" align="char" char=".">1.1</td>
              <td style="border:none;" align="char" char=".">3.6</td>
            </tr>
            <tr>
              <td style="border:none;" align="char" char=".">&gt;0.9</td>
              <td style="border:none;" align="char" char=".">1.3</td>
              <td style="border:none;" align="char" char=".">1.8</td>
              <td style="border:none;" align="char" char=".">0.5</td>
              <td style="border:none;" align="char" char=".">0.8</td>
              <td style="border:none;" align="char" char=".">0.3</td>
              <td style="border:none;" align="char" char=".">0.8</td>
            </tr>
            <tr>
              <td colspan="7" style="border:none;" align="left" char=".">SC<sub>RDKit</sub> Fragments</td>
            </tr>
            <tr>
              <td style="border:none;" align="char" char=".">&gt;0.7</td>
              <td style="border:none;" align="char" char=".">60.2</td>
              <td style="border:none;" align="char" char=".">71.3</td>
              <td style="border:none;" align="char" char=".">28.4</td>
              <td style="border:none;" align="char" char=".">39.1</td>
              <td style="border:none;" align="char" char=".">24.2</td>
              <td style="border:none;" align="char" char=".">38.7</td>
            </tr>
            <tr>
              <td style="border:none;" align="char" char=".">&gt;0.8</td>
              <td style="border:none;" align="char" char=".">24.7</td>
              <td style="border:none;" align="char" char=".">35.8</td>
              <td style="border:none;" align="char" char=".">8.7</td>
              <td style="border:none;" align="char" char=".">12.7</td>
              <td style="border:none;" align="char" char=".">6.1</td>
              <td style="border:none;" align="char" char=".">12.3</td>
            </tr>
            <tr>
              <td style="border:none;" align="char" char=".">&gt;0.9</td>
              <td style="border:none;" align="char" char=".">4.5</td>
              <td style="border:none;" align="char" char=".">8.2</td>
              <td style="border:none;" align="char" char=".">1.4</td>
              <td style="border:none;" align="char" char=".">2.3</td>
              <td style="border:none;" align="char" char=".">0.5</td>
              <td style="border:none;" align="char" char=".">1.6</td>
            </tr>
            <tr>
              <td colspan="7" style="border:none;" align="left" char=".">RMSD Fragments</td>
            </tr>
            <tr>
              <td style="border:none;" align="char" char=".">&lt;1.00 Å</td>
              <td style="border:none;" align="char" char=".">46.9</td>
              <td style="border:none;" align="char" char=".">58.6</td>
              <td style="border:none;" align="char" char=".">19.4</td>
              <td style="border:none;" align="char" char=".">28.1</td>
              <td style="border:none;" align="char" char=".">14.6</td>
              <td style="border:none;" align="char" char=".">26.6</td>
            </tr>
            <tr>
              <td style="border:none;" align="char" char=".">&lt;0.75 Å</td>
              <td style="border:none;" align="char" char=".">20.5</td>
              <td style="border:none;" align="char" char=".">30.0</td>
              <td style="border:none;" align="char" char=".">7.1</td>
              <td style="border:none;" align="char" char=".">10.2</td>
              <td style="border:none;" align="char" char=".">4.3</td>
              <td style="border:none;" align="char" char=".">9.3</td>
            </tr>
            <tr>
              <td style="border:none;" align="char" char=".">&lt;0.50 Å</td>
              <td style="border:none;" align="char" char=".">5.7</td>
              <td style="border:none;" align="char" char=".">9.3</td>
              <td style="border:none;" align="char" char=".">2.0</td>
              <td style="border:none;" align="char" char=".">3.1</td>
              <td style="border:none;" align="char" char=".">0.9</td>
              <td style="border:none;" align="char" char=".">2.4</td>
            </tr>
          </tbody>
        </table>
        <table-wrap-foot>
          <fn id="t3fn1">
            <label>a</label>
            <p>See <xref rid="sec2" ref-type="other">Methods</xref>,
assessment metrics for a description of the metrics.</p>
          </fn>
        </table-wrap-foot>
      </table-wrap>
      <p>A molecule is deemed “valid”
if it contains both
starting fragments (i.e., the fragments have been linked), and its
SMILES representation can be parsed by RDKit<sup><xref ref-type="bibr" rid="ref43">43</xref></sup> (i.e., satisfies atomic valency rules). The small proportion of
invalid molecules produced by DeLinker (<xref rid="tbl2" ref-type="other">Table <xref rid="tbl2" ref-type="other">2</xref></xref>) was due to the fragments remaining unlinked,
rather than failing atomic valency. This is a design choice by the
deep learning system and is beneficial in reducing the number of unsuitable
linkers suggested.</p>
      <p>A fundamental benefit of our deep generative
method over any database
is evident in the proportion of novel linkers. The Database method
is unable to suggest linkers not in the database, and thus 0% of the
proposals were novel. In contrast, DeLinker proposed a linker not
in the training set in around 40% of suggestions, despite the training
set of linkers containing over 5000 unique linkers. Examples of novel
linkers proposed by DeLinker are shown in <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/acs.jcim.9b01120/suppl_file/ci9b01120_si_002.pdf">Figure S1</ext-link>.</p>
      <p>Both methods recovered over 75% of the original molecules
(<xref rid="tbl2" ref-type="other">Table <xref rid="tbl2" ref-type="other">2</xref></xref>), demonstrating
that
they are able to sample from the distribution of linkers effectively.
However, this is in part due to the chemical redundancy of molecules
in ZINC. Indeed, all of the original linkers in the held-out ZINC
test set were present in the training set.</p>
      <p>DeLinker was able
to learn the 2D filters implicitly, although
it produced slightly fewer molecules passing these filters than the
Database method (<xref rid="tbl2" ref-type="other">Table <xref rid="tbl2" ref-type="other">2</xref></xref>). Both methods had high success rates of 95% or above for all of
the individual filters (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/acs.jcim.9b01120/suppl_file/ci9b01120_si_002.pdf">Table S2</ext-link>).</p>
      <p>For all of the 3D measures at all thresholds assessed, DeLinker
produced a substantially higher proportion of linkers with the required
3D similarity than the Database (<xref rid="tbl3" ref-type="other">Table <xref rid="tbl3" ref-type="other">3</xref></xref>). In particular, at the highest levels of similarity,
DeLinker generated over 80% more molecules, scoring &gt;0.9 for SC<sub>RDKit</sub> Fragments and over 60% more molecules with an RMSD &lt;
0.5Å.</p>
      <p>Performance of both methods is impacted by the length
of the generated
linkers and in particular the number of short (three/four atoms) linkers
in the test set (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/acs.jcim.9b01120/suppl_file/ci9b01120_si_002.pdf">Table S1</ext-link>), where there
are a limited number of possibilities. The degree of outperformance
of DeLinker over the Database increased substantially when only considering
linkers with at least five atoms (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/acs.jcim.9b01120/suppl_file/ci9b01120_si_002.pdf">Table S4</ext-link>). In this setting, DeLinker generated around 190% more molecules,
scoring &gt;0.9 for SC<sub>RDKit</sub> Fragments and 130% more molecules
with RMSD Fragments &lt;0.5 Å or SC<sub>RDKit</sub> Molecule
&gt;0.9.</p>
    </sec>
    <sec id="sec3.3">
      <title>Validation on CASF</title>
      <p>We saw similar performance when
we evaluated the methods on the CASF data set (<xref rid="tbl2" ref-type="other">Tables <xref rid="tbl2" ref-type="other">2</xref></xref> and <xref rid="tbl3" ref-type="other">3</xref>). Both methods
found producing 3D similar molecules more challenging for the CASF
set than for the held-out ZINC set. Two possible explanations are
the lower molecular similarity and use of experimentally determined
structures in the evaluation. The average Tanimoto similarity of the
Morgan fingerprints<sup><xref ref-type="bibr" rid="ref52">52</xref></sup> (radius 2, 1024 bits)
of the 250 most similar starting fragments in the training set to
each starting point in the test set was 0.36 for the held-out ZINC
set but only 0.26 for the CASF set. However, our method was still
frequently able to generate compounds with high similarity to the
original molecule (<xref rid="tbl3" ref-type="other">Table <xref rid="tbl3" ref-type="other">3</xref></xref>).</p>
      <p>In particular, DeLinker generated around 60% more
molecules than the Database at the highest 3D similarity threshold
(&gt;0.9 SC<sub>RDKit</sub> Fragments and SC<sub>RDKit</sub> Molecule,
&lt;0.5 Å RMSD Fragments). When restricting the evaluation to
linkers with at least five atoms, the degree of outperformance substantially
increased, with DeLinker producing 200% more molecules that scored
&gt;0.9 by SC<sub>RDKit</sub> Fragments than the Database (<xref rid="tbl3" ref-type="other">Table <xref rid="tbl3" ref-type="other">3</xref></xref>).</p>
      <p>DeLinker
recovered 54% of the original linkers, compared to only
43% for the Database method, while around 50% of molecules generated
by DeLinker were novel. The proportion recovered was lower than in
the evaluation on ZINC; however, this set is more challenging with
an average length of the true linker 5.9 atoms, compared to 4.9 for
the held-out ZINC test set and 4.7 for the ZINC training set. In addition,
only around 70% of the true linkers were present in the training set,
providing an upper bound for the Database method. Similar to the ZINC
set, DeLinker substantially outperformed the Database method for longer
linkers; DeLinker recovered around 30% of molecules with a linker
of at least five atoms, twice as many as the Database method that
only recovered 15% (<xref rid="tbl2" ref-type="other">Table <xref rid="tbl2" ref-type="other">2</xref></xref>).</p>
      <p>As previously noted, a fundamental limitation of
a database method
is an inability to generate linkers that are not present in the database.
Despite being trained on the same database of linkers, DeLinker has
learnt to extrapolate from this set to novel linkers. The following
is an example of when this is crucial for successful compound design.</p>
      <p>Dequalinium is a nanomolar binder (Ki: 70 nM) of chitinase A (PDB
ID: 3ARP, <xref rid="fig4" ref-type="fig">Figure <xref rid="fig4" ref-type="fig">4</xref></xref>b).<sup><xref ref-type="bibr" rid="ref53">53</xref></sup> One possible fragmentation of the dequalinium–chitinase
complex is shown in <xref rid="fig4" ref-type="fig">Figure <xref rid="fig4" ref-type="fig">4</xref></xref>a. To recover dequalinium from these fragments requires joining
them with a decane linker, which is not present in the training set
of linkers and thus the Database is unable to recover the original
molecule. We generated 250 molecules with DeLinker, which included
several highly similar novel linkers. The five most similar measured
by SC<sub>RDKit</sub> Fragments are shown in <xref rid="fig4" ref-type="fig">Figure <xref rid="fig4" ref-type="fig">4</xref></xref>c. While DeLinker did not recover the decane
linker within 250 generated compounds, simple chain linkers that closely
resemble the true decane linker are prevalent. We compared this to
an exhaustive search of linkers in the Database of the same length
as the true decane linker (790 unique molecules). None of the Database-generated
molecules are highly similar to dequalinium (<xref rid="fig4" ref-type="fig">Figure <xref rid="fig4" ref-type="fig">4</xref></xref>d), with only one molecule with SC<sub>RDKit</sub> Fragments &gt;0.7. In contrast, DeLinker generated 34 unique molecules
with SC<sub>RDKit</sub> Fragments &gt;0.7. This illustrates the importance
of <italic>de novo</italic> design and the limitations of any database-based
solution.</p>
      <fig id="fig4" position="float">
        <label>Figure 4</label>
        <caption>
          <p>Comparison of DeLinker with an exhaustive Database search. A fragmention
of dequalinium (PDB ID: 3ARP, (b)) is shown in (a). The most 3D similar
molecules by SC<sub>RDKit</sub> Fragments proposed by DeLinker and
the Database method are shown in (c) and (d), respectively, together
with the 3D similarity score. (c) DeLinker was able to produce several
very similar molecules, despite limited sampling (250 samples). (d)
Exhaustive search of the database was not able to recover the original
molecule or produce any highly similar molecules.</p>
        </caption>
        <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ci9b01120_0001" id="gr4" position="float"/>
      </fig>
      <p>Finally, we showed the applicability of our method in three diverse
examples from the literature, covering fragment linking,<sup><xref ref-type="bibr" rid="ref49">49</xref></sup> scaffold hopping,<sup><xref ref-type="bibr" rid="ref50">50</xref></sup> and PROTAC design.<sup><xref ref-type="bibr" rid="ref51">51</xref></sup> Due to the availability
of independent experimental structural data for both the initial and
optimized complexes, this represents the most realistic evaluation,
albeit with limited sample size.</p>
    </sec>
    <sec id="sec3.4">
      <title>Fragment Linking Case Study</title>
      <p>Trapero et al.<sup><xref ref-type="bibr" rid="ref49">49</xref></sup> considered both growing
and linking strategies
to create potent inhibitors of inosine 5-monophosphate dehydrogenase
(IMPDH, UniProt: G7CNL4), a tuberculosis drug target. Linking proved
most successful, with the authors identifying several promising compounds,
the most potent with more than 1000-fold improvement in affinity over
the initial fragment hits. Three direct elaborations of the initial
fragments were reported (compounds 29–31 in Table 4 of Trapero
et al.<sup><xref ref-type="bibr" rid="ref49">49</xref></sup>), with structures of both the
initial fragments (PDB ID: 5OU2) and most potent linked compound (PDB
ID: 5OU3) available (<xref rid="fig5" ref-type="fig">Figure <xref rid="fig5" ref-type="fig">5</xref></xref>a).</p>
      <fig id="fig5" position="float">
        <label>Figure 5</label>
        <caption>
          <p>Fragment linking case study. (a) Left: the initial fragment hits
(5OU2). Right: the most potent experimentally verified linked molecule
of Trapero et al.<sup><xref ref-type="bibr" rid="ref49">49</xref></sup> (PDB ID: 5OU3). DeLinker
recovered this and two other experimentally verified active molecules.
(b) 3D similarity metrics and AutoDock Vina Minimized Affinities.
Unique ligands with SC<sub>RDKit</sub> Fragments &gt;0.8 were docked
with AutoDock Vina using a local minimization. DeLinker produced more
than twice as many molecules than the Database method with better
Vina scores than the most potent reported binder (Lead).</p>
        </caption>
        <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ci9b01120_0002" id="gr5" position="float"/>
      </fig>
      <p>In previous experiments, we chose the linker length based
on the
number of atoms in the linker of the original molecule. To reflect
prospective use more accurately, we assumed that the linker length
was unknown and generated 1000 linkers for each length between 3 and
11 atoms, inclusively. We assessed the generated linkers using the
same criteria as before.</p>
      <p>Both DeLinker and the Database method
recovered all three experimentally
validated compounds. However, DeLinker identified more than twice
as many unique compounds as the Database with high 3D similarity (&gt;0.8
SC<sub>RDKit</sub> Fragments) to the initial fragments (301 vs 129, <xref rid="fig5" ref-type="fig">Figure <xref rid="fig5" ref-type="fig">5</xref></xref>b and <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/acs.jcim.9b01120/suppl_file/ci9b01120_si_002.pdf">Table S5</ext-link>). The compounds meeting the above 3D
similarity threshold were docked with AutoDock Vina<sup><xref ref-type="bibr" rid="ref54">54</xref>,<xref ref-type="bibr" rid="ref55">55</xref></sup> via a local minimization after alignment with the starting fragments.
This allows us to understand whether the proposed molecules are complementary
to the active site and are able to maintain the binding mode of the
original fragments. Around 40% of molecules generated by both DeLinker
and the Database were scored better than the most potent experimentally
validated compound. As a result, DeLinker suggested more than twice
as many unique compounds as the Database with better docking scores
than the active compound (123 vs 51, <xref rid="fig5" ref-type="fig">Figure <xref rid="fig5" ref-type="fig">5</xref></xref>b).</p>
    </sec>
    <sec id="sec3.5">
      <title>Scaffold Hopping Case Study</title>
      <p>Kamenecka
et al.<sup><xref ref-type="bibr" rid="ref50">50</xref></sup> designed JNK3-selective (UniProt:
P53779) inhibitors
that had &gt;1000-fold selectivity over p38 (UniProt: Q16539), another
closely related mitogen-activated protein kinase family member. Starting
with an indazole class of compounds, they were not able to establish
significant selectivity for JNK3 over p38. However, changing scaffolds
led to an aminopyrazole linker that afforded compounds with &gt;2800-fold
selectivity. The two inhibitors displayed nearly identical binding
mode (RMSD 0.33 Å, <xref rid="fig6" ref-type="fig">Figure <xref rid="fig6" ref-type="fig">6</xref></xref>a) and affinity for JNK3 (indazole: IC<sub>50</sub> 12 nM,
aminopyrazole: IC<sub>50</sub> 25 nM) but significantly different
binding affinity to p38 (indazole: IC<sub>50</sub> 3.2 nM, aminopyrazole
IC<sub>50</sub> 3.6 μM).</p>
      <fig id="fig6" position="float">
        <label>Figure 6</label>
        <caption>
          <p>Scaffold hopping case study. (a) Overlay
of the indazole (PDB ID
3FI3, magenta carbons) and aminopyrazole (PDB ID 3FI2, cyan carbons)
structures, with JNK3 shown in green. DeLinker recovered both active
molecules, despite neither linker being in the training set. (b) Structures
of the indazole (left) and aminopyrazole (right) linkers and their
Murcko scaffolds. (c) Overlay of the indazole compound (PDB ID 3FI3,
magenta carbons) and example linkers (yellow carbons) from several
highly 3D similar scaffolds.</p>
        </caption>
        <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ci9b01120_0003" id="gr6" position="float"/>
      </fig>
      <p>Starting with the indazole-based inhibitor (PDB ID: 3FI3), we explored
the ability of our method to change molecular scaffold, in particular,
toward the aminopyrazole-based inhibitor (PDB ID: 3FI2). We generated
5000 linkers with both eight and nine atoms and assessed the generated
linkers using the same criteria as before. In particular, we focused
on the diversity of molecular scaffolds proposed by DeLinker that
satisfied the 3D structural information and could adopt a highly similar
conformation to the original indazole-based inhibitor.</p>
      <p>Of the
10 000 compounds generated by DeLinker, there were
2688 unique compounds that satisfied the 2D chemical filters (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/acs.jcim.9b01120/suppl_file/ci9b01120_si_002.pdf">Table S6</ext-link>). Six hundred and ninety-nine of these
had an SC<sub>RDKit</sub> fragment score of above 0.75, of which 627
were not in the training set (89.7% novel). These compounds covered
182 unique generic Murko scaffolds.<sup><xref ref-type="bibr" rid="ref56">56</xref></sup> Five
of the most common are shown in <xref rid="fig6" ref-type="fig">Figure <xref rid="fig6" ref-type="fig">6</xref></xref>b, together with an example linker and the number of
unique linkers generated with the same generic Murko scaffold that
also met the 3D similarity threshold. The examples from all five scaffolds
show an almost perfect overlap with the indazole linker while maintaining
the conformation of the remainder of the molecule.</p>
      <p>In addition,
DeLinker recovered both the indazole- and aminopyrazole-based
linkers, despite neither being present in the training set.</p>
    </sec>
    <sec id="sec3.6">
      <title>PROTAC
Case Study</title>
      <p>Farnaby et al.<sup><xref ref-type="bibr" rid="ref51">51</xref></sup> developed
PROTAC degraders of the BAF ATPase subunits SMARCA2
(UniProt: P51531) and SMARCA4 (UniProt: P51532) using a bromodomain
ligand and recruitment of the E3 ubiquitin ligase VHL (UniProt: P40337).
They first designed a PROTAC by combining known binders of SMARCA2/4
and E3 ubiquitin ligase VHL using poly(ethylene glycol)-based linkers
(PDB ID: 6HAY, <xref rid="fig7" ref-type="fig">Figure <xref rid="fig7" ref-type="fig">7</xref></xref>a). The linker was then optimized to improve interactions with the
lipophilic face created in part by Y98 of the VHL protein. In particular,
they designed the linker to mimic the conformation observed in the
ternary complex structure, resulting in improved molecular recognition
(PDB ID: 6HAX). This was confirmed by the two crystal structures displaying
near-identical ternary complexes (<xref rid="fig7" ref-type="fig">Figure <xref rid="fig7" ref-type="fig">7</xref></xref>b).</p>
      <fig id="fig7" position="float">
        <label>Figure 7</label>
        <caption>
          <p>PROTAC design case study. (a) Two-dimensional
chemical structures
of PROTAC 1 and PROTAC 2. (b) Overlays of ternary crystal structures
of PROTAC 1 (PDB ID 6HAY, magenta carbons) and PROTAC 2 (PDB ID 6HAX,
yellow carbons), with SMARCA2 shown in orange and VHL in blue. (c)
Overlays of three linkers with different scaffolds produced by DeLinker
(green carbons); all three accurately recapitulate the linker geometry
observed in PROTAC 2 (yellow carbons). None of these linkers were
present in the training set.</p>
        </caption>
        <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ci9b01120_0004" id="gr7" position="float"/>
      </fig>
      <p>We investigated the ability of our model to design alternative
linkers to the known poly(ethylene glycol)-based linker (PDB ID: 6HAY)
that could maintain the same conformation observed in the ternary
complex. We generated 5000 linkers with a maximum of either 9 or 10
atoms. There were almost 3000 unique linkers that passed the 2D chemical
filters (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/acs.jcim.9b01120/suppl_file/ci9b01120_si_002.pdf">Table S7</ext-link>).</p>
      <p>Due to the size
and complexity of the PROTAC, we generated conformers
constraining the two starting substructures (<xref rid="fig7" ref-type="fig">Figure <xref rid="fig7" ref-type="fig">7</xref></xref>a) to adopt poses close to their known binding
conformation, removing any high-energy poses. DeLinker produced 2150
unique compounds with SC<sub>RDKit</sub> Fragments &gt;0.85, of which
three novel linkers that accurately recapitulate the linker geometry
observed in PROTAC 2 are shown in <xref rid="fig7" ref-type="fig">Figure <xref rid="fig7" ref-type="fig">7</xref></xref>c. In all three cases, the aromatic systems
perfectly align with that of PROTAC 2 and are likely to fulfill the
goal of improving interactions with the lipophilic face compared to
PROTAC 1. In particular, the pyrrole-based linker (<xref rid="fig7" ref-type="fig">Figure <xref rid="fig7" ref-type="fig">7</xref></xref>c, left)
appears to be making an NH−π interaction with the Y98
residue, possibly improving the CH−π interaction being
made by the benzene in PROTAC 2. When the structures were minimized
using AutoDock Vina,<sup><xref ref-type="bibr" rid="ref54">54</xref>,<xref ref-type="bibr" rid="ref55">55</xref></sup> the compound with the pyrrole-based
linker scored comparably to PROTAC 2 (−14.17 vs −14.32),
with both scoring substantially better than PROTAC 1 (−12.66).
However, we note that AutoDock Vina does not model electrostatics
explicitly and thus does not capture NH−π or CH−π
interactions. The other two compounds shown (<xref rid="fig7" ref-type="fig">Figure <xref rid="fig7" ref-type="fig">7</xref></xref>c, center, right) scored better than PROTAC
2 (−14.81 and −14.33 respectively), as did almost 20%
of all of the minimized compounds (536).</p>
      <p>For each of the three
case studies, the top 20 molecules generated
by DeLinker that met the 3D similarity threshold (SC<sub>RDKit</sub> Fragments &gt;0.80) ranked by AutoDock Vina<sup><xref ref-type="bibr" rid="ref54">54</xref>,<xref ref-type="bibr" rid="ref55">55</xref></sup> score are shown in <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/acs.jcim.9b01120/suppl_file/ci9b01120_si_002.pdf">Figures S2–S4</ext-link>.</p>
    </sec>
  </sec>
  <sec id="sec4">
    <title>Conclusions</title>
    <p>We have developed a graph-based deep generative
method for fragment
linking or scaffold hopping that integrates 3D structural information,
utilizing the relative distance and orientation between the starting
substructures in the design process. Unlike previous attempts at computational
fragment linking or scaffold hopping, our method does not rely on
a database of fragments from which to select a linker but instead
designs one given the fragments provided and 3D information.</p>
    <p>Through two large-scale assessments, we have demonstrated that
our generative method is able to learn to produce a distribution of
linkers that matches the constraints present in the training set,
while being able to generalize to novel linkers that satisfy both
2D and 3D constraints. In addition, the generated molecules consistently
have high 3D similarity to both the initial fragments and the original
molecules, outperforming a Database baseline by 60% in the evaluation
on CASF, increasing to 200% when restricting the evaluation to linkers
with at least five atoms.</p>
    <p>Finally, through three case studies,
we have shown that our method
can be applied to fragment linking, scaffold hopping, and PROTAC design.
In the fragment linking example, our method reproduced all of the
reported potent molecules using only the crystal data of the initial
fragment hits. In addition, in docking-based evaluation, many of the
generated molecules were scored more highly than the original hits
while maintaining similar binding modes. In the scaffold hopping case
study, our method reproduced both the starting and final molecules,
while suggesting many other scaffolds with high 3D similarity to the
initial crystal data. Finally, in the PROTAC design case study, our
method suggested a range of novel linkers that met the design goal
of maintaining the linker geometry of PROTAC 1, while improving interactions
with the lipophilic face created in part by residue Y98 of the VHL
protein.</p>
    <p>Our generative model can be readily combined with previous
methods
for fragment linking or scaffold hopping.<sup><xref ref-type="bibr" rid="ref27">27</xref>−<xref ref-type="bibr" rid="ref32">32</xref></sup> This can be achieved by using the compounds generated by DeLinker
to augment the database that is used as input for the search and filtering
methods adopted by existing database-based methods.</p>
    <p>As is frequently
the case with machine-learning-based generative
models, some of the molecules generated by DeLinker might have unstable
functional groups or be hard to synthesize. We have demonstrated that
our method was able to learn to produce molecules that frequently
passed the 2D filters used to construct the training set through implicit
supervision alone, thus, altering the training set composition would
likely reduce the number of undesirable molecules generated. The properties
of generated molecules could also potentially be improved through
direct supervision with reinforcement learning<sup><xref ref-type="bibr" rid="ref57">57</xref></sup> or filtered via a postprocessing approach.<sup><xref ref-type="bibr" rid="ref58">58</xref></sup></p>
    <p>As far as we are aware, this is the first molecular
generative
model to incorporate 3D structural information directly in the design
process. Currently, the only 3D information utilized by the model
is the distance between the fragments or starting substructures and
their relative orientations. This provides explicit constraints for
a given compound but only implicit information about the shape of
the binding site. Despite this minimal parametrization, there is a
substantial impact on the generated molecules.</p>
    <p>Extending our
method to use additional structural information that
incorporates further constraints from the protein is a direction for
future research. This could be achieved directly by providing our
method with a richer representation of the protein–ligand binding
site or indirectly through the combination of reinforcement learning<sup><xref ref-type="bibr" rid="ref8">8</xref>,<xref ref-type="bibr" rid="ref59">59</xref>,<xref ref-type="bibr" rid="ref60">60</xref></sup> and existing methods from structure-based
drug discovery.<sup><xref ref-type="bibr" rid="ref54">54</xref>,<xref ref-type="bibr" rid="ref55">55</xref>,<xref ref-type="bibr" rid="ref61">61</xref>,<xref ref-type="bibr" rid="ref62">62</xref></sup> Both directions promise substantial benefits
for structure-based molecular generative methods.</p>
    <p>While we have
shown that our method can be applied to fragment
linking, scaffold hopping, and PROTAC design, we believe that our
framework is general and readily extendable to other design tasks.
Applications of DeLinker to other design tasks such as fragment growing,
R-group optimization, and macrocycle design would be interesting avenues
for further studies.</p>
    <p>The code is available at <uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://github.com/oxpig/DeLinker">https://github.com/oxpig/DeLinker</uri>.</p>
  </sec>
</body>
<back>
  <notes id="notes-1" notes-type="si">
    <title>Supporting Information Available</title>
    <p>The Supporting Information
is available free of charge at <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/10.1021/acs.jcim.9b01120?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.jcim.9b01120</ext-link>.<list id="silist" list-type="simple"><list-item><p>Details on the implementation
of DeLinker and data curation;
distribution of number of atoms contained in the original linkers
in the data sets utilized (Table S1); ablation study for DeLinker
on the held-out ZINC test set (Tables S2 and S3); 2D and 3D metrics
for molecules generated by DeLinker compared to a Database baseline
on the held-out ZINC test set (Table S4); fragment linking case study
(Table S5); scaffold hopping case study (Table S6); PROTAC design
case study (Table S7); a random sample of 50 novel linkers generated
by DeLinker during testing on the held-out ZINC data set (Figure S1);
and 20 example molecules generated by DeLinker for each of the case
studies (Figures S2–S4) (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/acs.jcim.9b01120/suppl_file/ci9b01120_si_001.txt">PDF</ext-link>)</p></list-item></list></p>
  </notes>
  <sec sec-type="supplementary-material">
    <title>Supplementary Material</title>
    <supplementary-material content-type="local-data" id="sifile1">
      <media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ci9b01120_si_001.txt">
        <caption>
          <p>ci9b01120_si_001.txt</p>
        </caption>
      </media>
    </supplementary-material>
    <supplementary-material content-type="local-data" id="sifile2">
      <media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ci9b01120_si_002.pdf">
        <caption>
          <p>ci9b01120_si_002.pdf</p>
        </caption>
      </media>
    </supplementary-material>
  </sec>
  <notes notes-type="COI-statement" id="NOTES-d7e1936-autogenerated">
    <p>The authors declare no
competing financial interest.</p>
  </notes>
  <ack>
    <title>Acknowledgments</title>
    <p>The authors thank Veerabahu Shanmugasundaram
for helpful discussions
on PROTACs. F.I. is supported by the EPSRC (Reference: EP/N509711/1).</p>
  </ack>
  <ref-list>
    <title>References</title>
    <ref id="ref1">
      <mixed-citation publication-type="journal" id="cit1"><name><surname>Polishchuk</surname><given-names>P. G.</given-names></name>; <name><surname>Madzhidov</surname><given-names>T. I.</given-names></name>; <name><surname>Varnek</surname><given-names>A.</given-names></name><article-title>Estimation of the Size of Drug-Like
Chemical Space Based on GDB-17 Data</article-title>. <source>J. Comput.-Aided
Mol. Des.</source><year>2013</year>, <volume>27</volume>, <fpage>675</fpage>–<lpage>679</lpage>. <pub-id pub-id-type="doi">10.1007/s10822-013-9672-4</pub-id>.<pub-id pub-id-type="pmid">23963658</pub-id></mixed-citation>
    </ref>
    <ref id="ref2">
      <mixed-citation publication-type="journal" id="cit2"><name><surname>Stumpfe</surname><given-names>D.</given-names></name>; <name><surname>Bajorath</surname><given-names>J.</given-names></name><article-title>Exploring Activity
Cliffs in Medicinal Chemistry</article-title>. <source>J. Med. Chem.</source><year>2012</year>, <volume>55</volume>, <fpage>2932</fpage>–<lpage>2942</lpage>. <pub-id pub-id-type="doi">10.1021/jm201706b</pub-id>.<pub-id pub-id-type="pmid">22236250</pub-id></mixed-citation>
    </ref>
    <ref id="ref3">
      <mixed-citation publication-type="journal" id="cit3"><name><surname>Venkatasubramanian</surname><given-names>V.</given-names></name>; <name><surname>Chan</surname><given-names>K.</given-names></name>; <name><surname>Caruthers</surname><given-names>J.</given-names></name><article-title>Computer-Aided Molecular Design Using
Genetic Algorithms</article-title>. <source>Comput. Chem. Eng.</source><year>1994</year>, <volume>18</volume>, <fpage>833</fpage>–<lpage>844</lpage>. <pub-id pub-id-type="doi">10.1016/0098-1354(93)E0023-3</pub-id>.</mixed-citation>
    </ref>
    <ref id="ref4">
      <mixed-citation publication-type="journal" id="cit4"><name><surname>Besnard</surname><given-names>J.</given-names></name>; <name><surname>Ruda</surname><given-names>G. F.</given-names></name>; <name><surname>Setola</surname><given-names>V.</given-names></name>; <name><surname>Abecassis</surname><given-names>K.</given-names></name>; <name><surname>Rodriguiz</surname><given-names>R. M.</given-names></name>; <name><surname>Huang</surname><given-names>X.-P.</given-names></name>; <name><surname>Norval</surname><given-names>S.</given-names></name>; <name><surname>Sassano</surname><given-names>M. F.</given-names></name>; <name><surname>Shin</surname><given-names>A. I.</given-names></name>; <name><surname>Webster</surname><given-names>L. A.</given-names></name>; <name><surname>Simeons</surname><given-names>F. R. C.</given-names></name>; <name><surname>Stojanovski</surname><given-names>L.</given-names></name>; <name><surname>Prat</surname><given-names>A.</given-names></name>; <name><surname>Seidah</surname><given-names>N. G.</given-names></name>; <name><surname>Constam</surname><given-names>D. B.</given-names></name>; <name><surname>Bickerton</surname><given-names>G. R.</given-names></name>; <name><surname>Read</surname><given-names>K. D.</given-names></name>; <name><surname>Wetsel</surname><given-names>W. C.</given-names></name>; <name><surname>Gilbert</surname><given-names>I. H.</given-names></name>; <name><surname>Roth</surname><given-names>B. L.</given-names></name>; <name><surname>Hopkins</surname><given-names>A. L.</given-names></name><article-title>Automated Design of Ligands to Polypharmacological
Profiles</article-title>. <source>Nature</source><year>2012</year>, <volume>492</volume>, <fpage>215</fpage>–<lpage>220</lpage>. <pub-id pub-id-type="doi">10.1038/nature11691</pub-id>.<pub-id pub-id-type="pmid">23235874</pub-id></mixed-citation>
    </ref>
    <ref id="ref5">
      <mixed-citation publication-type="journal" id="cit5"><name><surname>Hussain</surname><given-names>J.</given-names></name>; <name><surname>Rea</surname><given-names>C.</given-names></name><article-title>Computationally Efficient Algorithm to Identify Matched Molecular
Pairs (MMPs) in Large Data Sets</article-title>. <source>J. Chem. Inf.
Model.</source><year>2010</year>, <volume>50</volume>, <fpage>339</fpage>–<lpage>348</lpage>. <pub-id pub-id-type="doi">10.1021/ci900450m</pub-id>.<pub-id pub-id-type="pmid">20121045</pub-id></mixed-citation>
    </ref>
    <ref id="ref6">
      <mixed-citation publication-type="undeclared" id="cit6"><person-group person-group-type="allauthors"><name><surname>Guimaraes</surname><given-names>G. L.</given-names></name>; <name><surname>Sanchez-Lengeling</surname><given-names>B.</given-names></name>; <name><surname>Outeiral</surname><given-names>C.</given-names></name>; <name><surname>Farias</surname><given-names>P. L. C.</given-names></name>; <name><surname>Aspuru-Guzik</surname><given-names>A.</given-names></name></person-group><article-title>Objective-Reinforced
Generative Adversarial Networks (ORGAN) for Sequence Generation Models</article-title>, arXiv preprint:1705.10843. arXiv.org e-Print archive. <uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://arxiv.org/abs/1705.10843">https://arxiv.org/abs/1705.10843</uri> (submitted May 30, <year>2017</year>).</mixed-citation>
    </ref>
    <ref id="ref7">
      <mixed-citation publication-type="journal" id="cit7"><name><surname>Segler</surname><given-names>M. H. S.</given-names></name>; <name><surname>Kogej</surname><given-names>T.</given-names></name>; <name><surname>Tyrchan</surname><given-names>C.</given-names></name>; <name><surname>Waller</surname><given-names>M. P.</given-names></name><article-title>Generating Focused
Molecule Libraries for Drug Discovery with Recurrent Neural Networks</article-title>. <source>ACS Cent. Sci.</source><year>2018</year>, <volume>4</volume>, <fpage>120</fpage>–<lpage>131</lpage>. <pub-id pub-id-type="doi">10.1021/acscentsci.7b00512</pub-id>.<pub-id pub-id-type="pmid">29392184</pub-id></mixed-citation>
    </ref>
    <ref id="ref8">
      <mixed-citation publication-type="journal" id="cit8"><name><surname>Popova</surname><given-names>M.</given-names></name>; <name><surname>Isayev</surname><given-names>O.</given-names></name>; <name><surname>Tropsha</surname><given-names>A.</given-names></name><article-title>Deep Reinforcement
Learning for De
Novo Drug Design</article-title>. <source>Sci. Adv.</source><year>2018</year>, <volume>4</volume>, <elocation-id>eaap7885</elocation-id><pub-id pub-id-type="doi">10.1126/sciadv.aap7885</pub-id>.<pub-id pub-id-type="pmid">30050984</pub-id></mixed-citation>
    </ref>
    <ref id="ref9">
      <mixed-citation publication-type="journal" id="cit9"><name><surname>Arús-Pous</surname><given-names>J.</given-names></name>; <name><surname>Blaschke</surname><given-names>T.</given-names></name>; <name><surname>Ulander</surname><given-names>S.</given-names></name>; <name><surname>Reymond</surname><given-names>J.-L.</given-names></name>; <name><surname>Chen</surname><given-names>H.</given-names></name>; <name><surname>Engkvist</surname><given-names>O.</given-names></name><article-title>Exploring the GDB-13 Chemical Space Using Deep Generative
Models</article-title>. <source>J. Cheminf.</source><year>2019</year>, <volume>11</volume>, <elocation-id>20</elocation-id><pub-id pub-id-type="doi">10.1186/s13321-019-0341-z</pub-id>.</mixed-citation>
    </ref>
    <ref id="ref10">
      <mixed-citation publication-type="journal" id="cit10"><name><surname>Gómez-Bombarelli</surname><given-names>R.</given-names></name>; <name><surname>Wei</surname><given-names>J. N.</given-names></name>; <name><surname>Duvenaud</surname><given-names>D.</given-names></name>; <name><surname>Hernández-Lobato</surname><given-names>J. M.</given-names></name>; <name><surname>Sánchez-Lengeling</surname><given-names>B.</given-names></name>; <name><surname>Sheberla</surname><given-names>D.</given-names></name>; <name><surname>Aguilera-Iparraguirre</surname><given-names>J.</given-names></name>; <name><surname>Hirzel</surname><given-names>T. D.</given-names></name>; <name><surname>Adams</surname><given-names>R. P.</given-names></name>; <name><surname>Aspuru-Guzik</surname><given-names>A.</given-names></name><article-title>Automatic
Chemical Design Using a Data-Driven Continuous Representation of Molecules</article-title>. <source>ACS Cent. Sci.</source><year>2018</year>, <volume>4</volume>, <fpage>268</fpage>–<lpage>276</lpage>. <pub-id pub-id-type="doi">10.1021/acscentsci.7b00572</pub-id>.<pub-id pub-id-type="pmid">29532027</pub-id></mixed-citation>
    </ref>
    <ref id="ref11">
      <mixed-citation publication-type="undeclared" id="cit11"><person-group person-group-type="allauthors"><name><surname>Li</surname><given-names>Y.</given-names></name>; <name><surname>Vinyals</surname><given-names>O.</given-names></name>; <name><surname>Dyer</surname><given-names>C.</given-names></name>; <name><surname>Pascanu</surname><given-names>R.</given-names></name>; <name><surname>Battaglia</surname><given-names>P.</given-names></name></person-group><article-title>Learning Deep Generative Models
of Graphs</article-title>, arXiv preprint:1803.03324. arXiv.org e-Print
archive. <uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://arxiv.org/abs/1803.03324">https://arxiv.org/abs/1803.03324</uri> (submitted Mar 8, <year>2018</year>).</mixed-citation>
    </ref>
    <ref id="ref12">
      <mixed-citation publication-type="conf-proc" id="cit12"><person-group person-group-type="allauthors"><name><surname>Jin</surname><given-names>W.</given-names></name>; <name><surname>Barzilay</surname><given-names>R.</given-names></name>; <name><surname>Jaakkola</surname><given-names>T. S.</given-names></name></person-group><source>Junction Tree Variational
Autoencoder for Molecular Graph Generation</source>, International
Conference on Machine Learning (ICML), <year>2018</year>; pp <fpage>2323</fpage>–<lpage>2332</lpage>.</mixed-citation>
    </ref>
    <ref id="ref13">
      <mixed-citation publication-type="conf-proc" id="cit13"><person-group person-group-type="allauthors"><name><surname>You</surname><given-names>J.</given-names></name>; <name><surname>Ying</surname><given-names>R.</given-names></name>; <name><surname>Ren</surname><given-names>X.</given-names></name>; <name><surname>Hamilton</surname><given-names>W.</given-names></name>; <name><surname>Leskovec</surname><given-names>J.</given-names></name></person-group><source>GraphRNN: Generating Realistic Graphs with
Deep Auto-regressive Models</source>, International Conference on
Machine Learning (ICML), <year>2018</year>; pp <fpage>5708</fpage>–<lpage>5717</lpage>.</mixed-citation>
    </ref>
    <ref id="ref14">
      <mixed-citation publication-type="conf-proc" id="cit14"><person-group person-group-type="allauthors"><name><surname>Liu</surname><given-names>Q.</given-names></name>; <name><surname>Allamanis</surname><given-names>M.</given-names></name>; <name><surname>Brockschmidt</surname><given-names>M.</given-names></name>; <name><surname>Gaunt</surname><given-names>A.</given-names></name></person-group><source>Constrained Graph Variational Autoencoders
for Molecule Design</source>, Advances in Neural Information Processing
Systems 31 (NeurIPS), <year>2018</year>; pp <fpage>7795</fpage>–<lpage>7804</lpage>.</mixed-citation>
    </ref>
    <ref id="ref15">
      <mixed-citation publication-type="journal" id="cit15"><name><surname>Li</surname><given-names>Y.</given-names></name>; <name><surname>Zhang</surname><given-names>L.</given-names></name>; <name><surname>Liu</surname><given-names>Z.</given-names></name><article-title>Multi-objective
De Novo Drug Design
with Conditional Graph Generative Model</article-title>. <source>J.
Cheminf.</source><year>2018</year>, <volume>10</volume>, <elocation-id>33</elocation-id><pub-id pub-id-type="doi">10.1186/s13321-018-0287-6</pub-id>.</mixed-citation>
    </ref>
    <ref id="ref16">
      <mixed-citation publication-type="conf-proc" id="cit16"><person-group person-group-type="allauthors"><name><surname>Jin</surname><given-names>W.</given-names></name>; <name><surname>Yang</surname><given-names>K.</given-names></name>; <name><surname>Barzilay</surname><given-names>R.</given-names></name>; <name><surname>Jaakkola</surname><given-names>T.</given-names></name></person-group><source>Learning
Multimodal Graph-to-Graph
Translation for Molecule Optimization</source>, International Conference
on Learning Representations (ICLR), <year>2019</year>.</mixed-citation>
    </ref>
    <ref id="ref17">
      <mixed-citation publication-type="journal" id="cit17"><name><surname>Sterling</surname><given-names>T.</given-names></name>; <name><surname>Irwin</surname><given-names>J. J.</given-names></name><article-title>ZINC 15 - Ligand Discovery for Everyone</article-title>. <source>J. Chem. Inf. Model.</source><year>2015</year>, <volume>55</volume>, <fpage>2324</fpage>–<lpage>2337</lpage>. <pub-id pub-id-type="doi">10.1021/acs.jcim.5b00559</pub-id>.<pub-id pub-id-type="pmid">26479676</pub-id></mixed-citation>
    </ref>
    <ref id="ref18">
      <mixed-citation publication-type="journal" id="cit18"><name><surname>Gaulton</surname><given-names>A.</given-names></name>; <name><surname>Hersey</surname><given-names>A.</given-names></name>; <name><surname>Nowotka</surname><given-names>M.</given-names></name>; <name><surname>Bento</surname><given-names>A. P.</given-names></name>; <name><surname>Chambers</surname><given-names>J.</given-names></name>; <name><surname>Mendez</surname><given-names>D.</given-names></name>; <name><surname>Mutowo</surname><given-names>P.</given-names></name>; <name><surname>Atkinson</surname><given-names>F.</given-names></name>; <name><surname>Bellis</surname><given-names>L. J.</given-names></name>; <name><surname>Cibrián-Uhalte</surname><given-names>E.</given-names></name>; <name><surname>Davies</surname><given-names>M.</given-names></name>; <name><surname>Dedman</surname><given-names>N.</given-names></name>; <name><surname>Karlsson</surname><given-names>A.</given-names></name>; <name><surname>Magariños</surname><given-names>M. P.</given-names></name>; <name><surname>Overington</surname><given-names>J. P.</given-names></name>; <name><surname>Papadatos</surname><given-names>G.</given-names></name>; <name><surname>Smit</surname><given-names>I.</given-names></name>; <name><surname>Leach</surname><given-names>A. R.</given-names></name><article-title>The ChEMBL Database
in 2017</article-title>. <source>Nucleic Acids Res.</source><year>2017</year>, <volume>45</volume>, <fpage>D945</fpage>–<lpage>D954</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkw1074</pub-id>.<pub-id pub-id-type="pmid">27899562</pub-id></mixed-citation>
    </ref>
    <ref id="ref19">
      <mixed-citation publication-type="journal" id="cit19"><name><surname>Gupta</surname><given-names>A.</given-names></name>; <name><surname>Müller</surname><given-names>A. T.</given-names></name>; <name><surname>Huisman</surname><given-names>B. J. H.</given-names></name>; <name><surname>Fuchs</surname><given-names>J. A.</given-names></name>; <name><surname>Schneider</surname><given-names>P.</given-names></name>; <name><surname>Schneider</surname><given-names>G.</given-names></name><article-title>Generative Recurrent Networks for De Novo Drug Design</article-title>. <source>Mol. Inf.</source><year>2018</year>, <volume>37</volume>, <elocation-id>1700111</elocation-id><pub-id pub-id-type="doi">10.1002/minf.201700111</pub-id>.</mixed-citation>
    </ref>
    <ref id="ref20">
      <mixed-citation publication-type="undeclared" id="cit20"><person-group person-group-type="allauthors"><name><surname>Jin</surname><given-names>W.</given-names></name>; <name><surname>Barzilay</surname><given-names>R.</given-names></name>; <name><surname>Jaakkola</surname><given-names>T.</given-names></name></person-group><article-title>Hierarchical Graph-to-Graph
Translation for Molecules</article-title>, arXiv preprint:1907.11223.
arXiv.org e-Print archive. https://arxiv.org/abs/1907.11223 (submitted
June 11, <year>2019</year>).</mixed-citation>
    </ref>
    <ref id="ref21">
      <mixed-citation publication-type="journal" id="cit21"><name><surname>Zhou</surname><given-names>Z.</given-names></name>; <name><surname>Kearnes</surname><given-names>S.</given-names></name>; <name><surname>Li</surname><given-names>L.</given-names></name>; <name><surname>Zare</surname><given-names>R. N.</given-names></name>; <name><surname>Riley</surname><given-names>P.</given-names></name><article-title>Optimization
of Molecules via Deep Reinforcement Learning</article-title>. <source>Sci. Rep.</source><year>2019</year>, <volume>9</volume>, <elocation-id>10752</elocation-id><pub-id pub-id-type="doi">10.1038/s41598-019-47148-x</pub-id>.<pub-id pub-id-type="pmid">31341196</pub-id></mixed-citation>
    </ref>
    <ref id="ref22">
      <mixed-citation publication-type="journal" id="cit22"><name><surname>Skalic</surname><given-names>M.</given-names></name>; <name><surname>Jiménez</surname><given-names>J.</given-names></name>; <name><surname>Sabbadin</surname><given-names>D.</given-names></name>; <name><surname>De Fabritiis</surname><given-names>G.</given-names></name><article-title>Shape-Based
Generative Modeling for De Novo Drug Design</article-title>. <source>J. Chem. Inf. Model.</source><year>2019</year>, <volume>59</volume>, <fpage>1205</fpage>–<lpage>1214</lpage>. <pub-id pub-id-type="doi">10.1021/acs.jcim.8b00706</pub-id>.<pub-id pub-id-type="pmid">30762364</pub-id></mixed-citation>
    </ref>
    <ref id="ref23">
      <mixed-citation publication-type="journal" id="cit23"><name><surname>Ichihara</surname><given-names>O.</given-names></name>; <name><surname>Barker</surname><given-names>J.</given-names></name>; <name><surname>Law</surname><given-names>R. J.</given-names></name>; <name><surname>Whittaker</surname><given-names>M.</given-names></name><article-title>Compound Design
by Fragment-Linking</article-title>. <source>Mol. Inf.</source><year>2011</year>, <volume>30</volume>, <fpage>298</fpage>–<lpage>306</lpage>. <pub-id pub-id-type="doi">10.1002/minf.201000174</pub-id>.</mixed-citation>
    </ref>
    <ref id="ref24">
      <mixed-citation publication-type="book" id="cit24"><person-group person-group-type="allauthors"><name><surname>Bienstock</surname><given-names>R. J.</given-names></name></person-group> In <source>Fragment-Based
Methods in Drug Discovery</source>; <person-group person-group-type="editor"><name><surname>Klon</surname><given-names>A. E.</given-names></name></person-group>, Ed.; <publisher-name>Springer</publisher-name>: <publisher-loc>New York</publisher-loc>, <year>2015</year>; pp <fpage>119</fpage>–<lpage>135</lpage>.</mixed-citation>
    </ref>
    <ref id="ref25">
      <mixed-citation publication-type="journal" id="cit25"><name><surname>Böhm</surname><given-names>H.-J.</given-names></name>; <name><surname>Flohr</surname><given-names>A.</given-names></name>; <name><surname>Stahl</surname><given-names>M.</given-names></name><article-title>Scaffold Hopping</article-title>. <source>Drug Discovery Today: Technol.</source><year>2004</year>, <volume>1</volume>, <fpage>217</fpage>–<lpage>224</lpage>. <pub-id pub-id-type="doi">10.1016/j.ddtec.2004.10.009</pub-id>.</mixed-citation>
    </ref>
    <ref id="ref26">
      <mixed-citation publication-type="journal" id="cit26"><name><surname>Langdon</surname><given-names>S. R.</given-names></name>; <name><surname>Ertl</surname><given-names>P.</given-names></name>; <name><surname>Brown</surname><given-names>N.</given-names></name><article-title>Bioisosteric Replacement
and Scaffold
Hopping in Lead Generation and Optimization</article-title>. <source>Mol. Inf.</source><year>2010</year>, <volume>29</volume>, <fpage>366</fpage>–<lpage>385</lpage>. <pub-id pub-id-type="doi">10.1002/minf.201000019</pub-id>.</mixed-citation>
    </ref>
    <ref id="ref27">
      <mixed-citation publication-type="journal" id="cit27"><name><surname>Böhm</surname><given-names>H.-J.</given-names></name><article-title>The Computer
Program LUDI: A New Method for the De Novo Design of Enzyme Inhibitors</article-title>. <source>J. Comput.-Aided Mol. Des.</source><year>1992</year>, <volume>6</volume>, <fpage>61</fpage>–<lpage>78</lpage>. <pub-id pub-id-type="doi">10.1007/BF00124387</pub-id>.<pub-id pub-id-type="pmid">1583540</pub-id></mixed-citation>
    </ref>
    <ref id="ref28">
      <mixed-citation publication-type="journal" id="cit28"><name><surname>Böhm</surname><given-names>H.-J.</given-names></name><article-title>LUDI: Rule-Based
Automatic Design of New Substituents for Enzyme Inhibitor Leads</article-title>. <source>J. Comput.-Aided Mol. Des.</source><year>1992</year>, <volume>6</volume>, <fpage>593</fpage>–<lpage>606</lpage>. <pub-id pub-id-type="doi">10.1007/BF00126217</pub-id>.<pub-id pub-id-type="pmid">1291628</pub-id></mixed-citation>
    </ref>
    <ref id="ref29">
      <mixed-citation publication-type="journal" id="cit29"><name><surname>Maass</surname><given-names>P.</given-names></name>; <name><surname>Schulz-Gasch</surname><given-names>T.</given-names></name>; <name><surname>Stahl</surname><given-names>M.</given-names></name>; <name><surname>Rarey</surname><given-names>M.</given-names></name><article-title>Recore: AFast and Versatile
Method for Scaffold Hopping Based on Small Molecule Crystal Structure
Conformations</article-title>. <source>J. Chem. Inf. Model.</source><year>2007</year>, <volume>47</volume>, <fpage>390</fpage>–<lpage>399</lpage>. <pub-id pub-id-type="doi">10.1021/ci060094h</pub-id>.<pub-id pub-id-type="pmid">17305328</pub-id></mixed-citation>
    </ref>
    <ref id="ref30">
      <mixed-citation publication-type="journal" id="cit30"><name><surname>Thompson</surname><given-names>D. C.</given-names></name>; <name><surname>Aldrin Denny</surname><given-names>R.</given-names></name>; <name><surname>Nilakantan</surname><given-names>R.</given-names></name>; <name><surname>Humblet</surname><given-names>C.</given-names></name>; <name><surname>Joseph-McCarthy</surname><given-names>D.</given-names></name>; <name><surname>Feyfant</surname><given-names>E.</given-names></name><article-title>CONFIRM: Connecting Fragments Found in Receptor Molecules</article-title>. <source>J. Comput.-Aided Mol. Des.</source><year>2008</year>, <volume>22</volume>, <elocation-id>761</elocation-id><pub-id pub-id-type="doi">10.1007/s10822-008-9221-8</pub-id>.<pub-id pub-id-type="pmid">18612831</pub-id></mixed-citation>
    </ref>
    <ref id="ref31">
      <mixed-citation publication-type="journal" id="cit31"><name><surname>Dey</surname><given-names>F.</given-names></name>; <name><surname>Caflisch</surname><given-names>A.</given-names></name><article-title>Fragment-Based
De Novo Ligand Design by Multiobjective
Evolutionary Optimization</article-title>. <source>J. Chem. Inf. Model.</source><year>2008</year>, <volume>48</volume>, <fpage>679</fpage>–<lpage>690</lpage>. <pub-id pub-id-type="doi">10.1021/ci700424b</pub-id>.<pub-id pub-id-type="pmid">18307332</pub-id></mixed-citation>
    </ref>
    <ref id="ref32">
      <mixed-citation publication-type="journal" id="cit32"><name><surname>Vainio</surname><given-names>M. J.</given-names></name>; <name><surname>Kogej</surname><given-names>T.</given-names></name>; <name><surname>Raubacher</surname><given-names>F.</given-names></name>; <name><surname>Sadowski</surname><given-names>J.</given-names></name><article-title>Scaffold Hopping by
Fragment Replacement</article-title>. <source>J. Chem. Inf. Model.</source><year>2013</year>, <volume>53</volume>, <fpage>1825</fpage>–<lpage>1835</lpage>. <pub-id pub-id-type="doi">10.1021/ci4001019</pub-id>.<pub-id pub-id-type="pmid">23826858</pub-id></mixed-citation>
    </ref>
    <ref id="ref33">
      <mixed-citation publication-type="journal" id="cit33"><name><surname>Elton</surname><given-names>D. C.</given-names></name>; <name><surname>Boukouvalas</surname><given-names>Z.</given-names></name>; <name><surname>Fuge</surname><given-names>M. D.</given-names></name>; <name><surname>Chung</surname><given-names>P. W.</given-names></name><article-title>Deep Learning for
Molecular Design-A Review of the State of the Art</article-title>. <source>Mol. Syst. Des. Eng.</source><year>2019</year>, <volume>4</volume>, <fpage>828</fpage>–<lpage>849</lpage>. <pub-id pub-id-type="doi">10.1039/C9ME00039A</pub-id>.</mixed-citation>
    </ref>
    <ref id="ref34">
      <mixed-citation publication-type="undeclared" id="cit34"><person-group person-group-type="allauthors"><name><surname>O’Boyle</surname><given-names>N.</given-names></name>; <name><surname>Dalke</surname><given-names>A.</given-names></name></person-group><source>DeepSMILES: An Adaptation
of SMILES for Use in Machine-Learning of Chemical Structures</source>, <year>2018</year>.</mixed-citation>
    </ref>
    <ref id="ref35">
      <mixed-citation publication-type="undeclared" id="cit35"><person-group person-group-type="allauthors"><name><surname>Krenn</surname><given-names>M.</given-names></name>; <name><surname>Häse</surname><given-names>F.</given-names></name>; <name><surname>Nigam</surname><given-names>A.</given-names></name>; <name><surname>Friederich</surname><given-names>P.</given-names></name>; <name><surname>Aspuru-Guzik</surname><given-names>A.</given-names></name></person-group><article-title>SELFIES: A Robust
Representation
of Semantically Constrained Graphs with an Example Application in
Chemistry</article-title>, abs/1905.13741. arXiv.org e-Print archive. <uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://arxiv.org/abs/1905.13741">https://arxiv.org/abs/1905.13741</uri> (submitted on May 31, <year>2019</year>).</mixed-citation>
    </ref>
    <ref id="ref36">
      <mixed-citation publication-type="undeclared" id="cit36"><person-group person-group-type="allauthors"><name><surname>Arús-Pous</surname><given-names>J.</given-names></name>; <name><surname>Patronov</surname><given-names>A.</given-names></name>; <name><surname>Bjerrum</surname><given-names>E. J.</given-names></name>; <name><surname>Tyrchan</surname><given-names>C.</given-names></name>; <name><surname>Reymond</surname><given-names>J.-L.</given-names></name>; <name><surname>Chen</surname><given-names>H.</given-names></name>; <name><surname>Engkvist</surname><given-names>O.</given-names></name></person-group><article-title>SMILES-Based
Deep Generative Scaffold Decorator for De-Novo Drug Design</article-title>, ChemRxiv preprint:chemrxiv.11638383.v1. arXiv.org e-Print archive. <uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.26434/chemrxiv.11638383.v1">https://doi.org/10.26434/chemrxiv.11638383.v1</uri> (submitted Jan 17, <year>2020</year>).</mixed-citation>
    </ref>
    <ref id="ref37">
      <mixed-citation publication-type="journal" id="cit37"><name><surname>Li</surname><given-names>Y.</given-names></name>; <name><surname>Hu</surname><given-names>J.</given-names></name>; <name><surname>Wang</surname><given-names>Y.</given-names></name>; <name><surname>Zhou</surname><given-names>J.</given-names></name>; <name><surname>Zhang</surname><given-names>L.</given-names></name>; <name><surname>Liu</surname><given-names>Z.</given-names></name><article-title>DeepScaffold:
A Comprehensive Tool for Scaffold-Based De Novo Drug Discovery Using
Deep Learning</article-title>. <source>J. Chem. Inf. Model.</source><year>2020</year>, <volume>60</volume>, <fpage>77</fpage>–<lpage>91</lpage>. <pub-id pub-id-type="doi">10.1021/acs.jcim.9b00727</pub-id>.<pub-id pub-id-type="pmid">31809029</pub-id></mixed-citation>
    </ref>
    <ref id="ref38">
      <mixed-citation publication-type="journal" id="cit38"><name><surname>Ståhl</surname><given-names>N.</given-names></name>; <name><surname>Falkman</surname><given-names>G.</given-names></name>; <name><surname>Karlsson</surname><given-names>A.</given-names></name>; <name><surname>Mathiason</surname><given-names>G.</given-names></name>; <name><surname>Boström</surname><given-names>J.</given-names></name><article-title>Deep Reinforcement Learning for Multiparameter Optimization
in De novo Drug Design</article-title>. <source>J. Chem. Inf. Model.</source><year>2019</year>, <volume>59</volume>, <fpage>3166</fpage>–<lpage>3176</lpage>. <pub-id pub-id-type="doi">10.1021/acs.jcim.9b00325</pub-id>.<pub-id pub-id-type="pmid">31273995</pub-id></mixed-citation>
    </ref>
    <ref id="ref39">
      <mixed-citation publication-type="conf-proc" id="cit39"><person-group person-group-type="allauthors"><name><surname>Li</surname><given-names>Y.</given-names></name>; <name><surname>Tarlow</surname><given-names>D.</given-names></name>; <name><surname>Brockschmidt</surname><given-names>M.</given-names></name>; <name><surname>Zemel</surname><given-names>R.</given-names></name></person-group><source>Gated Graph Sequence
Neural Networks</source>, International Conference on Learning Representations
(ICLR), <year>2016</year>.</mixed-citation>
    </ref>
    <ref id="ref40">
      <mixed-citation publication-type="conf-proc" id="cit40"><person-group person-group-type="allauthors"><name><surname>Zhu</surname><given-names>J.-Y.</given-names></name>; <name><surname>Zhang</surname><given-names>R.</given-names></name>; <name><surname>Pathak</surname><given-names>D.</given-names></name>; <name><surname>Darrell</surname><given-names>T.</given-names></name>; <name><surname>Efros</surname><given-names>A.
A.</given-names></name>; <name><surname>Wang</surname><given-names>O.</given-names></name>; <name><surname>Shechtman</surname><given-names>E.</given-names></name></person-group>, <source>Toward Multimodal Image-to-Image
Translation</source>, Advances in Neural Information Processing Systems
30 (NeurIPS), <year>2017</year>; pp <fpage>465</fpage>–<lpage>476</lpage>.</mixed-citation>
    </ref>
    <ref id="ref41">
      <mixed-citation publication-type="journal" id="cit41"><name><surname>Ertl</surname><given-names>P.</given-names></name>; <name><surname>Schuffenhauer</surname><given-names>A.</given-names></name><article-title>Estimation
of Synthetic Accessibility Score of Drug-Like
Molecules Based on Molecular Complexity and Fragment Contributions</article-title>. <source>J. Cheminf.</source><year>2009</year>, <volume>1</volume>, <elocation-id>8</elocation-id><pub-id pub-id-type="doi">10.1186/1758-2946-1-8</pub-id>.</mixed-citation>
    </ref>
    <ref id="ref42">
      <mixed-citation publication-type="journal" id="cit42"><name><surname>Baell</surname><given-names>J. B.</given-names></name>; <name><surname>Holloway</surname><given-names>G. A.</given-names></name><article-title>New Substructure
Filters for Removal of Pan Assay Interference
Compounds (PAINS) from Screening Libraries and for Their Exclusion
in Bioassays</article-title>. <source>J. Med. Chem.</source><year>2010</year>, <volume>53</volume>, <fpage>2719</fpage>–<lpage>2740</lpage>. <pub-id pub-id-type="doi">10.1021/jm901137j</pub-id>.<pub-id pub-id-type="pmid">20131845</pub-id></mixed-citation>
    </ref>
    <ref id="ref43">
      <mixed-citation publication-type="weblink" id="cit43"><person-group person-group-type="allauthors"><name><surname>Landrum</surname><given-names>G.</given-names></name></person-group><article-title>RDKit: Open-Source
Cheminformatics</article-title>. <uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://www.rdkit.org/">http://www.rdkit.org/</uri> (accessed November 4, <year>2019</year>).</mixed-citation>
    </ref>
    <ref id="ref44">
      <mixed-citation publication-type="journal" id="cit44"><name><surname>Ebejer</surname><given-names>J.-P.</given-names></name>; <name><surname>Morris</surname><given-names>G. M.</given-names></name>; <name><surname>Deane</surname><given-names>C. M.</given-names></name><article-title>Freely
Available Conformer Generation
Methods: How Good Are They</article-title>. <source>J. Chem. Inf. Model.</source><year>2012</year>, <volume>52</volume>, <fpage>1146</fpage>–<lpage>1158</lpage>. <pub-id pub-id-type="doi">10.1021/ci2004658</pub-id>.<pub-id pub-id-type="pmid">22482737</pub-id></mixed-citation>
    </ref>
    <ref id="ref45">
      <mixed-citation publication-type="journal" id="cit45"><name><surname>Su</surname><given-names>M.</given-names></name>; <name><surname>Yang</surname><given-names>Q.</given-names></name>; <name><surname>Du</surname><given-names>Y.</given-names></name>; <name><surname>Feng</surname><given-names>G.</given-names></name>; <name><surname>Liu</surname><given-names>Z.</given-names></name>; <name><surname>Li</surname><given-names>Y.</given-names></name>; <name><surname>Wang</surname><given-names>R.</given-names></name><article-title>Comparative Assessment of Scoring Functions: The CASF-2016
Update</article-title>. <source>J. Chem. Inf. Model.</source><year>2019</year>, <volume>59</volume>, <fpage>895</fpage>–<lpage>913</lpage>. <pub-id pub-id-type="doi">10.1021/acs.jcim.8b00545</pub-id>.<pub-id pub-id-type="pmid">30481020</pub-id></mixed-citation>
    </ref>
    <ref id="ref46">
      <mixed-citation publication-type="journal" id="cit46"><name><surname>Brown</surname><given-names>N.</given-names></name>; <name><surname>Fiscato</surname><given-names>M.</given-names></name>; <name><surname>Segler</surname><given-names>M. H. S.</given-names></name>; <name><surname>Vaucher</surname><given-names>A. C.</given-names></name><article-title>GuacaMol:
Benchmarking
Models for De Novo Molecular Design</article-title>. <source>J. Chem.
Inf. Model.</source><year>2019</year>, <volume>59</volume>, <fpage>1096</fpage>–<lpage>1108</lpage>. <pub-id pub-id-type="doi">10.1021/acs.jcim.8b00839</pub-id>.<pub-id pub-id-type="pmid">30887799</pub-id></mixed-citation>
    </ref>
    <ref id="ref47">
      <mixed-citation publication-type="journal" id="cit47"><name><surname>Putta</surname><given-names>S.</given-names></name>; <name><surname>Landrum</surname><given-names>G. A.</given-names></name>; <name><surname>Penzotti</surname><given-names>J. E.</given-names></name><article-title>Conformation
Mining: An Algorithm
for Finding Biologically Relevant Conformations</article-title>. <source>J. Med. Chem</source><year>2005</year>, <volume>48</volume>, <fpage>3313</fpage>–<lpage>3318</lpage>. <pub-id pub-id-type="doi">10.1021/jm049066l</pub-id>.<pub-id pub-id-type="pmid">15857136</pub-id></mixed-citation>
    </ref>
    <ref id="ref48">
      <mixed-citation publication-type="journal" id="cit48"><name><surname>Landrum</surname><given-names>G. A.</given-names></name>; <name><surname>Penzotti</surname><given-names>J. E.</given-names></name>; <name><surname>Putta</surname><given-names>S.</given-names></name><article-title>Feature-map
Vectors: A New Class
of Informative Descriptors for Computational Drug Discovery</article-title>. <source>J. Comput.-Aided Mol. Des.</source><year>2007</year>, <volume>20</volume>, <fpage>751</fpage>–<lpage>762</lpage>. <pub-id pub-id-type="doi">10.1007/s10822-006-9085-8</pub-id>.</mixed-citation>
    </ref>
    <ref id="ref49">
      <mixed-citation publication-type="journal" id="cit49"><name><surname>Trapero</surname><given-names>A.</given-names></name>; <name><surname>Pacitto</surname><given-names>A.</given-names></name>; <name><surname>Singh</surname><given-names>V.</given-names></name>; <name><surname>Sabbah</surname><given-names>M.</given-names></name>; <name><surname>Coyne</surname><given-names>A. G.</given-names></name>; <name><surname>Mizrahi</surname><given-names>V.</given-names></name>; <name><surname>Blundell</surname><given-names>T. L.</given-names></name>; <name><surname>Ascher</surname><given-names>D. B.</given-names></name>; <name><surname>Abell</surname><given-names>C.</given-names></name><article-title>Fragment-Based
Approach to Targeting Inosine-5-monophosphate Dehydrogenase (IMPDH)
from <italic>Mycobacterium tuberculosis</italic></article-title>. <source>J. Med. Chem</source><year>2018</year>, <volume>61</volume>, <fpage>2806</fpage>–<lpage>2822</lpage>. <pub-id pub-id-type="doi">10.1021/acs.jmedchem.7b01622</pub-id>.<pub-id pub-id-type="pmid">29547284</pub-id></mixed-citation>
    </ref>
    <ref id="ref50">
      <mixed-citation publication-type="journal" id="cit50"><name><surname>Kamenecka</surname><given-names>T.</given-names></name>; <name><surname>Habel</surname><given-names>J.</given-names></name>; <name><surname>Duckett</surname><given-names>D.</given-names></name>; <name><surname>Chen</surname><given-names>W.</given-names></name>; <name><surname>Ling</surname><given-names>Y. Y.</given-names></name>; <name><surname>Frackowiak</surname><given-names>B.</given-names></name>; <name><surname>Jiang</surname><given-names>R.</given-names></name>; <name><surname>Shin</surname><given-names>Y.</given-names></name>; <name><surname>Song</surname><given-names>X.</given-names></name>; <name><surname>LoGrasso</surname><given-names>P.</given-names></name><article-title>Structure-Activity
Relationships and X-ray Structures
Describing the Selectivity of Aminopyrazole Inhibitors for c-Jun N-terminal
Kinase 3 (JNK3) over p38</article-title>. <source>J. Biol. Chem.</source><year>2009</year>, <volume>284</volume>, <fpage>12853</fpage>–<lpage>12861</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M809430200</pub-id>.<pub-id pub-id-type="pmid">19261605</pub-id></mixed-citation>
    </ref>
    <ref id="ref51">
      <mixed-citation publication-type="journal" id="cit51"><name><surname>Farnaby</surname><given-names>W.</given-names></name>; <name><surname>Koegl</surname><given-names>M.</given-names></name>; <name><surname>Roy</surname><given-names>M. J.</given-names></name>; <name><surname>Whitworth</surname><given-names>C.</given-names></name>; <name><surname>Diers</surname><given-names>E.</given-names></name>; <name><surname>Trainor</surname><given-names>N.</given-names></name>; <name><surname>Zollman</surname><given-names>D.</given-names></name>; <name><surname>Steurer</surname><given-names>S.</given-names></name>; <name><surname>Karolyi- Oezguer</surname><given-names>J.</given-names></name>; <name><surname>Riedmueller</surname><given-names>C.</given-names></name>; <name><surname>Gmaschitz</surname><given-names>T.</given-names></name>; <name><surname>Wachter</surname><given-names>J.</given-names></name>; <name><surname>Dank</surname><given-names>C.</given-names></name>; <name><surname>Galant</surname><given-names>M.</given-names></name>; <name><surname>Sharps</surname><given-names>B.</given-names></name>; <name><surname>Rumpel</surname><given-names>K.</given-names></name>; <name><surname>Traxler</surname><given-names>E.</given-names></name>; <name><surname>Gerstberger</surname><given-names>T.</given-names></name>; <name><surname>Schnitzer</surname><given-names>R.</given-names></name>; <name><surname>Petermann</surname><given-names>O.</given-names></name>; <name><surname>Greb</surname><given-names>P.</given-names></name>; <name><surname>Weinstabl</surname><given-names>H.</given-names></name>; <name><surname>Bader</surname><given-names>G.</given-names></name>; <name><surname>Zoephel</surname><given-names>A.</given-names></name>; <name><surname>Weiss- Puxbaum</surname><given-names>A.</given-names></name>; <name><surname>Ehrenhöfer-Wölfer</surname><given-names>K.</given-names></name>; <name><surname>Wöhrle</surname><given-names>S.</given-names></name>; <name><surname>Boehmelt</surname><given-names>G.</given-names></name>; <name><surname>Rinnenthal</surname><given-names>J.</given-names></name>; <name><surname>Arnhof</surname><given-names>H.</given-names></name>; <name><surname>Wiechens</surname><given-names>N.</given-names></name>; <name><surname>Wu</surname><given-names>M.-Y.</given-names></name>; <name><surname>Owen-Hughes</surname><given-names>T.</given-names></name>; <name><surname>Ettmayer</surname><given-names>P.</given-names></name>; <name><surname>Pearson</surname><given-names>M.</given-names></name>; <name><surname>McConnell</surname><given-names>D. B.</given-names></name>; <name><surname>Ciulli</surname><given-names>A.</given-names></name><article-title>BAF Complex Vulnerabilities in Cancer
Demonstrated via Structure-Based PROTAC Design</article-title>. <source>Nat. Chem. Biol.</source><year>2019</year>, <volume>15</volume>, <fpage>672</fpage>–<lpage>680</lpage>. <pub-id pub-id-type="doi">10.1038/s41589-019-0294-6</pub-id>.<pub-id pub-id-type="pmid">31178587</pub-id></mixed-citation>
    </ref>
    <ref id="ref52">
      <mixed-citation publication-type="journal" id="cit52"><name><surname>Rogers</surname><given-names>D.</given-names></name>; <name><surname>Hahn</surname><given-names>M.</given-names></name><article-title>Extended-Connectivity
Fingerprints</article-title>. <source>J. Chem.
Inf. Model.</source><year>2010</year>, <volume>50</volume>, <fpage>742</fpage>–<lpage>754</lpage>. <pub-id pub-id-type="doi">10.1021/ci100050t</pub-id>.<pub-id pub-id-type="pmid">20426451</pub-id></mixed-citation>
    </ref>
    <ref id="ref53">
      <mixed-citation publication-type="journal" id="cit53"><name><surname>Pantoom</surname><given-names>S.</given-names></name>; <name><surname>Vetter</surname><given-names>I. R.</given-names></name>; <name><surname>Prinz</surname><given-names>H.</given-names></name>; <name><surname>Suginta</surname><given-names>W.</given-names></name><article-title>Potent Family-18 Chitinase
Inhibitors: X-ray Structures, Affinities, and Binding Mechanisms</article-title>. <source>J. Biol. Chem.</source><year>2011</year>, <volume>286</volume>, <fpage>24312</fpage>–<lpage>24323</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M110.183376</pub-id>.<pub-id pub-id-type="pmid">21531720</pub-id></mixed-citation>
    </ref>
    <ref id="ref54">
      <mixed-citation publication-type="journal" id="cit54"><name><surname>Trott</surname><given-names>O.</given-names></name>; <name><surname>Olson</surname><given-names>A.</given-names></name><article-title>AutoDock Vina: Improving the Speed and Accuracy of Docking with a
New Scoring Function, Efficient Optimization and Multithreading</article-title>. <source>J. Comput. Chem.</source><year>2010</year>, <volume>31</volume>, <fpage>455</fpage>–<lpage>461</lpage>. <pub-id pub-id-type="doi">10.1002/jcc.21334</pub-id>.<pub-id pub-id-type="pmid">19499576</pub-id></mixed-citation>
    </ref>
    <ref id="ref55">
      <mixed-citation publication-type="journal" id="cit55"><name><surname>Koes</surname><given-names>D. R.</given-names></name>; <name><surname>Baumgartner</surname><given-names>M. P.</given-names></name>; <name><surname>Camacho</surname><given-names>C. J.</given-names></name><article-title>Lessons Learned in Empirical Scoring
with smina From the CSAR 2011 Benchmarking Exercise</article-title>. <source>J. Chem. Inf. Model.</source><year>2013</year>, <volume>53</volume>, <fpage>1893</fpage>–<lpage>1904</lpage>. <pub-id pub-id-type="doi">10.1021/ci300604z</pub-id>.<pub-id pub-id-type="pmid">23379370</pub-id></mixed-citation>
    </ref>
    <ref id="ref56">
      <mixed-citation publication-type="journal" id="cit56"><name><surname>Bemis</surname><given-names>G. W.</given-names></name>; <name><surname>Murcko</surname><given-names>M. A.</given-names></name><article-title>The Properties of
Known Drugs. 1. Molecular Frameworks</article-title>. <source>J. Med.
Chem</source><year>1996</year>, <volume>39</volume>, <fpage>2887</fpage>–<lpage>2893</lpage>. <pub-id pub-id-type="doi">10.1021/jm9602928</pub-id>.<pub-id pub-id-type="pmid">8709122</pub-id></mixed-citation>
    </ref>
    <ref id="ref57">
      <mixed-citation publication-type="undeclared" id="cit57"><person-group person-group-type="allauthors"><name><surname>Sanchez-Lengeling</surname><given-names>B.</given-names></name>; <name><surname>Outeiral</surname><given-names>C.</given-names></name>; <name><surname>Guimaraes</surname><given-names>G. L.</given-names></name>; <name><surname>Aspuru-Guzik</surname><given-names>A.</given-names></name></person-group><article-title>Optimizing
Distributions over Molecular Space. An Objective-Reinforced Generative
Adversarial Network for Inverse-Design Chemistry (ORGANIC)</article-title>, ChemRxiv preprint:chemrxiv.5309668.v3. arXiv.org e-Print archive.
https://doi.org/10.26434/chemrxiv.5309668.v3 (submitted Jan 1, <year>2017</year>).</mixed-citation>
    </ref>
    <ref id="ref58">
      <mixed-citation publication-type="journal" id="cit58"><name><surname>Sumita</surname><given-names>M.</given-names></name>; <name><surname>Yang</surname><given-names>X.</given-names></name>; <name><surname>Ishihara</surname><given-names>S.</given-names></name>; <name><surname>Tamura</surname><given-names>R.</given-names></name>; <name><surname>Tsuda</surname><given-names>K.</given-names></name><article-title>Hunting for
Organic Molecules with Artificial Intelligence: Molecules Optimized
for Desired Excitation Energies</article-title>. <source>ACS Cent. Sci.</source><year>2018</year>, <volume>4</volume>, <fpage>1126</fpage>–<lpage>1133</lpage>. <pub-id pub-id-type="doi">10.1021/acscentsci.8b00213</pub-id>.<pub-id pub-id-type="pmid">30276245</pub-id></mixed-citation>
    </ref>
    <ref id="ref59">
      <mixed-citation publication-type="journal" id="cit59"><name><surname>Williams</surname><given-names>R. J.</given-names></name><article-title>Simple
Statistical Gradient-Following Algorithms for Connectionist Reinforcement
Learning</article-title>. <source>Mach. Learn.</source><year>1992</year>, <volume>8</volume>, <fpage>229</fpage>–<lpage>256</lpage>. <pub-id pub-id-type="doi">10.1007/BF00992696</pub-id>.</mixed-citation>
    </ref>
    <ref id="ref60">
      <mixed-citation publication-type="journal" id="cit60"><name><surname>Olivecrona</surname><given-names>M.</given-names></name>; <name><surname>Blaschke</surname><given-names>T.</given-names></name>; <name><surname>Engkvist</surname><given-names>O.</given-names></name>; <name><surname>Chen</surname><given-names>H.</given-names></name><article-title>Molecular De-Novo Design
Through Deep Reinforcement Learning</article-title>. <source>J. Cheminf.</source><year>2017</year>, <volume>9</volume>, <elocation-id>48</elocation-id><pub-id pub-id-type="doi">10.1186/s13321-017-0235-x</pub-id>.</mixed-citation>
    </ref>
    <ref id="ref61">
      <mixed-citation publication-type="journal" id="cit61"><name><surname>Ragoza</surname><given-names>M.</given-names></name>; <name><surname>Hochuli</surname><given-names>J.</given-names></name>; <name><surname>Idrobo</surname><given-names>E.</given-names></name>; <name><surname>Sunseri</surname><given-names>J.</given-names></name>; <name><surname>Koes</surname><given-names>D. R.</given-names></name><article-title>Protein-Ligand
Scoring with Convolutional Neural Networks</article-title>. <source>J. Chem. Inf. Model.</source><year>2017</year>, <volume>57</volume>, <fpage>942</fpage>–<lpage>957</lpage>. <pub-id pub-id-type="doi">10.1021/acs.jcim.6b00740</pub-id>.<pub-id pub-id-type="pmid">28368587</pub-id></mixed-citation>
    </ref>
    <ref id="ref62">
      <mixed-citation publication-type="journal" id="cit62"><name><surname>Imrie</surname><given-names>F.</given-names></name>; <name><surname>Bradley</surname><given-names>A. R.</given-names></name>; <name><surname>van der
Schaar</surname><given-names>M.</given-names></name>; <name><surname>Deane</surname><given-names>C. M.</given-names></name><article-title>Protein Family-Specific
Models Using Deep Neural Networks and Transfer Learning Improve Virtual
Screening and Highlight the Need for More Data</article-title>. <source>J. Chem. Inf. Model.</source><year>2018</year>, <volume>58</volume>, <fpage>2319</fpage>–<lpage>2330</lpage>. <pub-id pub-id-type="doi">10.1021/acs.jcim.8b00350</pub-id>.<pub-id pub-id-type="pmid">30273487</pub-id></mixed-citation>
    </ref>
  </ref-list>
</back>
